地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18995651644
传真:15172431432
邮箱:sales@amyjet.com

QED Bioscience致力于为生物医药行业提供各类高品质抗体。
QED Bioscience has been designing and manufacturing antibodies for over 20 years, and throughout our history, our goals have remained unchanged: provide the best antibody products and services on the market and support our clients with the expertise and assistance they should expect from a full-spectrum antibody company like QED.
QED Bioscience develops novel monoclonal and polyclonal antibody products for our academic, biotechnology, diagnostic and pharmaceutical research clients. We develop these antibodies using the client’s small molecule, protein, or peptide targets, or by utilizing the target cDNA. We are a full-service corporation, and offer additional immunochemistry services such as purification and conjugation so that we can provide our clients with an antibody product that will work specifically within their system. We also develop monoclonal antibodies with pharmacological activity for enzyme neutralization and inhibition of receptor-ligand interactions, and anti-idiotypic antibodies.
QED Bioscience的主要产品包括:
Agriculture and Food Science Antibodies
Anti-Immunoglobulin Antibodies
Apoptosis Antibodies
Autophagy Antibodies
BioWarfare Antibodies
Cancer Research Antibodies
Cell Adhesion Molecule Antibodies
Coagulation Factor Antibodies
DNA/RNA/Oxidative Stress Antibodies
Drug Antibodies
Enzymes and Enzyme Inhibitor Antibodies
Epitope Tag Antibodies
Growth Factors/Cytokines/Receptor Antibodies
Heat Shock and Stress Protein Antibodies
Hormones and Serum Protein Antibodies
Infectious Disease Antibodies
Ion Channel Antibodies
Matrix Protein/MMP Antibodies
Neuroscience and Signal Transduction Antibodies
Phospho-specific Antibodies
Protein Transcription Antibodies
Reproductive Biology Antibodies
Secondary Antibodies
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
Nanostructured & Amorphous Materials, Inc.致力于纳米材料科技的应用。主要的业务包括:生产、研发、加工纳米级和非结晶材料。
Nanostructured & Amorphous Materials Inc. (NanoAmor) was founded in Los Alamos, New Mexico, USA, in September 2001. We are a leading nanomaterials company involved in all aspects of the business: manufacturing, research and development, processing, supplying and marketing of nanostructured materials and their dispersions.
Nanostructured & Amorphous Materials的主要产品包括:
Application-Oriented Carbon-Nanotubes Products
Carbon Nanotubes & Nanofibers
Carbon Nanotube Dispersions
Elements, Oxides, Carbides & Nitrides Nanoparticles
Fullerene
Graphenes, Graphene Oxides & Graphene Nanoplatelets
Graphene Film
Nanopowder Dispersions
Nanowires & Nanorods
Amorphous Ribbons
Nanocrystalline Ribbons
Amorphous & Nanocrystalline Cores
Amorphous and Nanocrystalline Magnetic Bars
Amorphous & Nanocrystalline Powders
Amorphous Brazing Foils
Superhard Materials
Surface-Modified Oxide Nanoparticles
| 品名 | 货号 | 规格 |
| CNTs Additives for Lithium-ion Battery | 1376YJ | 1kg; |
| Carbon Nanotubes Fibers | 1356YJ | meter; |
| Carbon Nanotubes Papers | 1348YJ | piece; |
| Carbon Nanotubes Films | 1350YJ | piece; |
| Carbon Nanotubes Films | 1351YJ | 咨询 |
| Water-based carbon nanotubes coatings | 1332YJ | kg; |
| Water-based carbon nanotubes coatings | 1333YJ | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJA | kg; |
| Antistatic carbon-nanotubes coatings | 1331YJB | kg; |
| Conductive/heating carbon-nanotubes coatings | 1378YJA | kg; |
| 20wt% CNTs/80wt% ABS Masterbatch | 1335YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HDPE Masterbatch | 1337YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% HIPS Masterbatch | 1338YJ | 1kg; 5kg; 10kg; |
| 25wt% CNTs/75wt% LLDPE Masterbatch | 1339YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PA6 Masterbatch | 1340YJ | 1kg; 5kg; 10kg; |
| 20wt% CNTs/80wt% PP Masterbatch | 1341YJ | 1kg; 5kg; 10kg; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Dispersion | 8040YJ | 500g; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Dispersion | 8042YJ | 500g; |
| 2 wt% MWCNTs (> 98%, D 5-15 nm)/Water Dispersion | 8028YJ | 500ml; |
| 2 wt% MWCNTs-COOH (> 98%, D 5-15 nm)/Water Dispersion | 8027YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/Water Dispersion | 8030YJ | 500 ml; |
| 10 wt% MWCNTs-COOH (>98%, D 30-80 nm)/Water Dispersion | 8029YJ | 500 ml; |
| 0.2 wt% SWCNTs (> 95%, D < 2 nm)/Water Paste | 8038YJ | kg; |
| 0.2 wt% SWCNTs-COOH (> 95%, OD 1-2 nm)/Water Paste | 8039YJ | 500g; kg; |
| 2 wt% MWCNTs (> 95%, D 5-15 nm)/Water Paste | 8032YJ | kg; |
| 2 wt% MWCNTs-COOH (> 95%, D 5-15 nm)/Water Paste | 8033YJ | kg; |
| 10 wt% MWCNTs (> 95%, D 30-80 nm)/Water Slurry | 8034YJ | kg; |
| 10 wt% MWCNTs-COOH (> 95%, D 30-80 nm)/Water Paste | 8035YJ | kg; |
| 12-14 wt% MWCNTs (> 95%, D 30-80 nm)/Water Paste | 8036YJ | kg; |
| 12-14 wt% MWCNTs-COOH (>95%, D 30-80 nm)/Water Paste | 8037YJ | kg; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/BA Dispersion | 8116YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMAC Dispersion | 8118YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/DMF Dispersion | 8115YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/IPA Dispersion | 8117YJ | 500 ml; |
| 0.2-0.3 wt% SWCNTs (> 95%, D 1-2 nm)/NMP Dispersion | 8114YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/BA Dispersion | 8124YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/BA Dispersion | 8123YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMAC Dispersion | 8126YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMAC Dispersion | 8125YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/DMF Dispersion | 8122YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/DMF Dispersion | 8121YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/IPA Dispersion | 8130YJ | 500 ml; |
| 8-10 wt% MWCNTs (> 98%, D 30-80 nm)/IPA Dispersion | 8129YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/NMP Dispersion | 8120YJ | 500 ml; |
| 5 wt% MWCNTs (> 98%, D 30-80 nm)/NMP Dispersion | 8119YJ | 500 ml; |
| 3 wt% MWCNTs (> 98%, D 5-15 nm)/PMA Dispersion | 8128YJ | 500 ml; |
| 10 wt% MWCNTs (> 98%, D 30-80 nm)/PMA Dispersion | 8127YJ | 500 ml; |
| Fullerence powder (C60, 95+%) | 8072YJ | 1g; 5g; |
| Fullerence powder (C60, 98+%) | 8073YJ | 1g; 5g; |
| Fullerence powder (C60, 99+%) | 8074YJ | 1g; 5g; |
| Fullerene powder (C60, 99.5+%) | 8075YJ | 1g; 5g; |
| Fullerene powder (C60, 99.9+%) | 8076YJ | 1g; 5g; |
| Fullerence powder (C70, 95+%) | 8077YJ | 1g; 5g; |
| Fullerence powder (C70, 98+%) | 8078YJ | 1g; 5g; |
| Fullerence powder (C70, 99+%) | 8079YJ | 1g; 5g; |
| Fullerenol Powder (hydroxylated fullerence C60) | 8080YJ | 1g; 10g; |
| Three-Dimensional Graphene (> 60 wt%, D 6-8 um, 3-4 layers) | 8109YJ | 1g; 5g; |
| 1.0-1.5 wt% Graphenes (> 98 wt%, Dia. 4-6 um, < 10 layers)/NMP paste | 8064YJ | 1g (graphene); 5g (graphene); |
| Highly Elastic Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8095YJ | 1 cylinder; 5 cylinders; |
| Ultra-light Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8093YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 1.2 cm, Height 1.2 cm) | 8090YJ | 1 cylinder; 5 cylinders; |
| Carbon Nanotubes (10 wt%) Doped Graphene Aerogel (Dia. 2.0 cm, Height 2.0 cm) | 8091YJ | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8096YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (47 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8096YJB | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 1 cm, Height 1 cm) | 8097YJA | 1 cylinder; 5 cylinders; |
| Magnetic Graphene Aerogel (63 wt% Fe3O4, Dia. 2 cm, Height 2 cm) | 8097YJB | 1 cylinder; 5 cylinders; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam (nickel foam etched, thickness 1-1.2 mm) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| 1-3 wt% Graphene Oxide (> 98 wt%, D 1-5 um, 1-2 layers)/Water Gel, pH = 3-4 | 8047YJB34 | 1g (graphene oxide); 5g (graphene oxide); |
| Graphene Oxide Paper (Dia. 9 cm, thickness 10 um) | 8089YJ | 1 piece; 5 pieces; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-13 um, < 30 layers) | 8055YJ2 | 50g; 250g; 1kg; |
| 5 wt% Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers)/NMP Paste | 8059YJ | kg (paste); |
| Industrial-Grade Graphene-Nanoplatelets/Carbon-Nanotubes Composites (> 90 wt%) | 8071YJ | 50g; 100g; |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/Water Paste | 8060YJ | kg (paste); |
| 5 wt% (Graphene Nanoplatelets & Carbon Nanotubes)/NMP Paste | 8061YJ | kg (paste); |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 97% area covered | 1301YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; 10 cm x 10 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on copper substrate, > 85% area covered | 1302YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on copper substrate | 1303YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 97% area covered | 1304YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/copper substrate, > 85% area covered | 1305YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layers) graphene/copper substrate | 1306YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 97% area covered | 1307YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/singled-layered graphene/PVC substrate, > 85% area covered | 1308YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| PMMA/multi-layered (< 10 layer) graphene/PVC substrate | 1309YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 97% area covered | 1310YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on silicon-oxide substrate, > 85% area covered | 1311YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on silicon-oxide substrate | 1312YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Single-layered graphene on quartz substrate, > 97% area covered | 1313YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on quartz substrate, > 85% area covered | 1314YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on quartz substrate | 1315YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 97% area covered | 1316YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Singled-layered graphene on PET substrate, > 85% area covered | 1317YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Multi-layered (< 10 layers) graphene on PET substrate | 1318YJ | 1 cm x 1 cm; 2 cm x 2 cm; 5 cm x 5 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene Foam on Nickel Foam (thickness 1-1.2 mm) | 1319YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Graphene on PVC (nickel foam removed) | 1320YJ | 1 cm * 1 cm; 2 cm * 2 cm; 5 cm * 5 cm; 5 cm * 10 cm; |
| Silver Nanopowder (Ag, 99.9+%, 20 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7031HW | 500ml; 1L; |
| Silver Nanopowder (Ag, 99.9+%, 50 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7033HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 100 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7035HW | 500ml; |
| Silver Nanopowder (Ag, 99.9+%, 200 nm) 0.1 - 1 wt% Dispersion in Water with Anionic Surfactant | 7038HW | 500ml; |
| Gold Nanopowder (Au, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7041HW | 500ml; |
| Platinum Nanopowder (Pt, 99.9+%, 20-30nm) 0.1wt% Dispersion in Water | 0488HW | 500ml; |
| Palladium Nanopowder (Pd, 99.99%, 20 nm) 0.1 - 1 wt% Dispersion in Water | 7051HW | 500ml; |
| Palladium Nanopowder (Pd, 99.9+%, 10 nm) 0.1wt% Dispersion in Water | 0466HW | kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) Dispersed in 850ml of Ethanol | 0388HW | 咨询 |
| Aluminum Oxide (alpha, 20 wt%, 30-60nm) in Water | 7017WJWA | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 30 nm) in Water | 7017WJWG | 1kg; |
| Aluminum Oxide (gamma, 20 wt%, 10 nm) in water | 7016WJWG | 1kg; |
| CuO, 1 wt%, in water, APS 30 nm | 9019WJ | kg; |
| Silicon Oxide (15 wt%, 30 nm) in water | 7019WJ | 30kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7015WJ | 1kg; |
| Silicon Oxide (25 wt%, 30 nm) in water | 7016WJ | 1kg; 10kg; |
| Titanium Oxide (Rutile, 40 wt%, 30-50 nm) in water | 7013WJWR | 1kg; |
| Titanium oxide TiO2 (40wt%, Rutile, 30-50 nm ) in Isopropanol | 5006WJ | kg; |
| Titanium Oxide (TiO2, Rutile, >99.5%, 5-30 nm,15 wt%) in water | 7012WJWR | 1kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in IPA | 7014WJWA | 1kg; |
| Titanium Oxide (Anatase, ATO doped, 20 wt%, 15-25 nm) Slurry | 7030WJ | 5kg; |
| Titanium Oxide (Anatase, 20 wt%, 5-30 nm) in water | 7012WJWA | 1kg; |
| Titanium Oxide (Anatase, 15 wt%, 5-30 nm) in water | 7011WJWA | 1kg; |
| Titanium Oxide (TiO2, Anatase, >99.5%, 15 nm, 15 wt%) in water, negatively charged | 7011WJWANC | 咨询 |
| Titanium Oxide Nanopowder (anatase, 5 wt%, 10-20 nm) in ethanol | 7019HT | 1L; 5L; |
| Zinc Oxide (20 wt%, 40 nm) in water | 7006WJ | 1L |
| Indium Tin Oxide (ITO, 30 wt%, 20-30 nm) in Water | 7026HZW | 100g; |
| Silver nanowires (Dia. 70 - 80 nm, Length > 10 um) | 0475HW6 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (Dia. 30 - 50 nm, Length > 10 um) | 0475HW5 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver Nanowires (Dia. 20 - 30 nm, Length > 10 um) | 0475HW4 | 1 g (silver nanowires); 5 g (silver nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW2E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW2I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 14-31 nm, L = 5-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW2W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW3E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW3I | 1 g (Ag nanowires); 2 g (Ag nanowires); 3 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 25-35 nm, L = 15-25 um, 99.95+%, 1 wt% Ag in water) | 0475NW3W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW5E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW5I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 35-45 nm, L = 10-20 um, 99.95+%, 1 wt% Ag in water) | 0475NW5W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in ethanol) | 0475NW6E | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in isopropanol) | 0475NW6I | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Silver nanowires (D = 55-75 nm, L = 20-40 um, 99.95+%, 1 wt% Ag in water) | 0475NW6W | 1 g (Ag nanowires); 2 g (Ag nanowires); 5 g (Ag nanowires); 10 g (Ag nanowires); |
| Single-walled Carbon nanotubes - 60%SWNTs (90%CNTs) | 1283YJ | 1g; 5g; |
| SWNT-OH (90% CNTs, 60% SWNTs) | 1285YJF | 1g; 5g; |
| SWNT-COOH (90% CNTs, 60% SWNTs) | 1287YJF | 1g; 5g; |
| Short SWNTs (90% CNTs, 60% SWNTs) | 1281YJS | 1g; 5g; |
| SWNT-OH (> 60%, OD 1-2 nm, Length 1-3 um) | 1285YJFS | 1g; |
| SWNT-COOH (> 60%, OD 1-2 nm, Length 1-3 um) | 1287YJFS | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | g; |
| Single-walled carbon nanotubes - 90%SWNTs (95%CNTs) | 1284YJ | g; 5g; |
| SWNT-OH (95% CNTs, 90% SWNTs) | 1286YJF | 1g; |
| SWNT-COOH (95% CNTs, 90% SWNTs) | 1288YJF | 1g; |
| SWCNTs (> 90%, OD 1-2 nm, Length 1-3 um) | 1246YJS | 1g; 5g; |
| Single-Walled Carbon Nanotubes (90+%), -OH Functionalized | 1586YJF | 1g; |
| Single-Walled Carbon Nanotubes (90+%), -COOH Functionalized | 1588YJF | 1g; |
| High-Purity SWNTs (> 95%, OD < 2 nm, Length 5-30 um) | 1288YJ | 1g; |
| High-Purity SWNTs, -OH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1368YJF | 1g; |
| High-Purity SWNTs, -COOH functionalized (> 95%, OD 1-2 nm, Length 5-30 um) | 1369YJF | 1g; |
| High-Purity Short SWNTs (> 95%, OD 1-2 nm, Length 1-3 um) | 1372YJ | 1g; |
| High-Purity Short SWNTs, -OH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1373YJF | 1g; |
| High-Purity Short SWNTs, -COOH Functionalized (> 95%, OD 1-2 nm, Length 1-3 um) | 1374YJF | 1g; |
| High-Purity SWNTs (> 95%), -NH2 functionalized | 1370YJF | 1g; 5g; |
| High-Purity Short SWNTs (> 95%), -NH2 functionalized | 1371YJFS | 1g; 5g; |
| High-Purity SWNTs (> 95 %, surface area > 1,075 m2/g) | 1300YJ | 1g; |
| DWNTs (> 60%, OD 2-4 nm, Length ~50 um) | 1280YJD | 1g; 5g; 25g; |
| DWNTs-COOH (> 60%, OD 2-4 nm, Length ~50 um) | 1281YJD | g; |
| Multi-Walled Carbon Nanotube -MWNT (98%, OD 4-6 nm) | 1389YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98%, OD 5-15 nm) | 1203YJ | 10g; 25g; |
| Multi-walled carbon nanotube -MWNT (99%, OD 5-15 nm) | 8101YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (95+%, OD 8-15 nm) | 1204YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 10-20 nm) | 1205YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 20-30 nm) | 1229YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (98+%, OD 30-50 nm) | 1231YJ | 10g; |
| Multi-wall carbon nanotube -MWNT (>98%, OD 30-80 nm) | 1233YJ | 10g; 25g; |
| Short MWNT (98+%, OD 4-6 nm, Length 0.5-2 um) | 1392YJS | 5g; |
| Short MWNT (98+%, OD 5-15 nm, Length 0.5-2 um) | 1225YJS | 5g; |
| Short MWNT (99+%, OD 5-15 nm, Length 0.5-2 um) | 8104YJS | 5g; |
| Short MWNT (95+%, OD 8-15 nm, Length 0.5-2 um) | 1235YJS | 5g; |
| Short MWNT (>98%, OD 10-20 nm, Length 0.5-2 um) | 1236YJS | 10g; |
| Short MWNT (98+%, OD 20-30 nm, Length 0.5-2 um) | 1237YJS | 5g; |
| Short MWNT (98+%, OD 30-50 nm, Length 0.5-2 um) | 1238YJS | 5g; |
| Short MWNT (98+%, OD 30-80 nm, Length 0.5-2 um) | 1227YJS | 5g; |
| Graphitized MWNT (99.9%, OD 8-15 nm) | 1219YJ | 10g; 25g; |
| Graphitized MWNT (99.9%, OD 10-20 nm) | 1220YJ | 10g; |
| Graphitized MWNT (99.9%, OD 20-30 nm) | 1221YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-50 nm) | 1222YJ | 5g; |
| Graphitized MWNT (99.9%, OD 30-80 nm) | 1223YJ | 5g; |
| Industrial-grade MWNT (95+%, OD 4-6 nm) | 1395YJ | 1kg; |
| Industrial-Grade MWNT (95+%, OD 5-15 nm) | 1201YJG | 1kg; |
| Industrial-grade MWNT (95%, OD 8-15 nm) | 1201YJA | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-20 nm) | 1201YJB | 1kg; |
| Industrial-grade MWNT (95+%, OD 10-30 nm) | 1201YJC | 1kg; |
| Industrial-grade MWNT (95+%, OD 20-40 nm) | 1201YJD | 1kg; |
| Industrial-Grade MWNT (95+%, OD 30-80 nm) | 1201YJE | 1kg; |
| MWNT-OH (98+%, OD 4-6 nm) | 1390YJF | 10g; |
| MWNT-OH (98+%, OD 5-15 nm) | 1261YJF | 5g; |
| MWNT-OH (99+%, OD 5-15 nm) | 8103YJF | 5g; |
| MWNT-OH (95+%, OD 8-15 nm) | 1262YJF | 5g; |
| MWNT-OH (98+%, OD 10-20 nm) | 1263YJF | 5g; |
| MWNT-OH (98+%, OD 20-30 nm) | 1264YJF | 5g; 25g; 100g; |
| MWNT-OH (98+%, OD 30-50 nm) | 1265YJF | 5g; |
| MWNT-OH (98+%, OD 30-80 nm) | 1266YJF | 5g; |
| Short MWNT-OH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1393YJF | 5 g; 100 g; |
| Short MWNT-OH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1247YJF | 5g; |
| Short MWNT-OH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8106YJF | 5g; |
| Short MWNT-OH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1248YJF | 5g; |
| Short MWNT-OH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1249YJF | 5g; |
| Short MWNT-OH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1251YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1252YJF | 5g; |
| Short MWNT-OH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1253YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 8-15 nm) | 1224YJF | 1g; |
| Graphitized MWNT-OH (99.9%, OD 10-20 nm) | 1228YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 20-30 nm) | 1235YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-50 nm) | 1239YJF | 1g; 5g; |
| Graphitized MWNT-OH (99.9%, OD 30-80 nm) | 1240YJF | 1g; 5g; |
| Industrial-grade MWNT-OH (95+%, OD 5-15 nm) | 1201YJI | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 8-15 nm) | 1201YJL | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 10-30 nm) | 1207YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 20-40 nm) | 1208YJF | 1kg; |
| Industrial-grade MWNT-OH (95+%, OD 30-80 nm) | 1209YJF | 1kg; |
| MWNT-COOH (98+%, OD 4-6 nm) | 1391YJF | 10g; |
| MWNT-COOH (98+%, OD 5-15 nm) | 1267YJF | 5g; |
| MWNT-COOH (99+%, OD 5-15 nm) | 8102YJF | 10g; |
| MWNT-COOH (95+%, OD 8-15 nm) | 1268YJF | 5g; |
| MWNT-COOH (98+%, OD 10-20 nm) | 1269YJF | 5g; |
| MWNT-COOH (98+%, OD 20-30 nm) | 1270YJF | 5g; |
| MWNT-COOH (98+%, OD 30-50 nm) | 1271YJF | 5g; |
| MWNT-COOH (98+%, OD 30-80 nm) | 1272YJF | 5g; |
| Short MWNT-COOH (98+%, OD 4-6 nm, Length 0.5-2 um) | 1394YJF | 5g; |
| Short MWNT-COOH (98+%, OD 5-15 nm, Length 0.5-2 um) | 1254YJF | 5g; |
| Short MWNT-COOH (99+%, OD 5-15 nm, Length 0.5-2 um) | 8105YJF | 5g; |
| Short MWNT-COOH (95+%, OD 8-15 nm, Length 0.5-2 um) | 1255YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 10-20 nm, Length 0.5-2 um) | 1256YJF | 5g; |
| Short MWNT-COOH (98+%, OD 20-30 nm, Length 0.5-2 um) | 1257YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-50 nm, Length 0.5-2 um) | 1259YJF | 1g; 5g; |
| Short MWNT-COOH (98+%, OD 30-80 nm, Length 0.5-2 um) | 1273YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 8-15 nm) | 1241YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 10-20 nm) | 1242YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 20-30 nm) | 1243YJF | 10g; |
| Graphitized MWNT-COOH (99.9%, OD 30-50 nm) | 1244YJF | 1g; 5g; |
| Graphitized MWNT-COOH (99.9%, OD 30-80 nm) | 1245YJF | 1g; 5g; |
| Industrial-grade MWNT-COOH (95+%, OD 5-15 nm) | 1201YJH | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 8-15 nm) | 1201YJK | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 10-30 nm) | 1210YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 20-40 nm) | 1216YJF | 1kg; |
| Industrial-grade MWNT-COOH (95+%, OD 30-80 nm) | 1218YJF | 1kg; |
| Aligned MWNT (98+%, OD 8-15 nm, Length: 30-50 um) | 1215YJA | 25g; |
| Carbon nanofibers (70+%, D = 200-600 nm, L = 5-50 um) | 1177YJ | 10g; |
| Carbon Nanofibers (95+%, D = 50-200 nm, L = 1-15 um) | 8107YJ | 10g; |
| Graphitized carbon nanofibers (95+%, OD = 50-200 nm, L = 1-15 um) | 1178YJ | 10g; |
| Graphene (> 98 wt%, D > 50 um, < 3 layers) | 2191YJ | 1g; 5g; |
| Graphene Oxide (> 99 wt%, D 0.5-3 um, < 3 Layers) | 2192YJ | 1g; 5g; |
| Graphene Nanoplatelets (> 99.5 wt%, D 5-10 um, < 20 layers) | 8056YJ | 1g; 5g; 25g; |
| Industrial-Grade Graphene Nanoplatelets (> 90 wt%, D 2-16 um, < 30 layers) | 8055YJ | 50g; 250g; 1kg; |
| *60% Ni/38% MWNT (95+%, OD 8-15 nm) | 1293YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 10-20 nm) | 1294YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 20-30 nm) | 1295YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-50 nm) | 1296YJ | 10g; |
| *60% Ni/38% MWNT (95+%, OD 30-80 nm) | 1297YJ | 10g; |
| MWNT-NH2 (95+%, OD 8-15 nm, 0.45 wt% amino) | 1562YJF | 5g; |
| Nitrogen-doped MWNTs (98%, OD 30-80 nm) | 8054YJ | 5g; |
| Large inner diameter thin-walled multi-walled carbon nanotubes | 1563YJF | 5g; |
| Coiled CNTs (60+%, OD 100-200 nm, Length 1-10 um) | 1298YJ | 5g; |
| Silver Nanopowder (Ag, 99.99%, 400 nm ) | 0487HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 200 nm ) | 0479HW | 咨询 |
| Silver Nanopowder (Ag, 99.99%, 100 nm ) | 0489HW | 咨询 |
| Silver Nanopowder (Ag, 99%, 90-210 nm) | 0471CD | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm ) | 0475HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 80 nm, w/~0.3% PVP ) | 0476HW | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 40 nm ) | 0473HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 40 nm, w/~0.3% PVP ) | 0474HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 30-50 nm, w/0.2 wt% PVP) | 0477YD | 咨询 |
| Silver Nanopowder (Ag, 35 nm, 99.5%, metal basis) | 0476JY | 咨询 |
| Silver Nanopowder (Ag, 99.9% , 20 nm ) | 0477HW | 咨询 |
| Silver Nanopowder (Ag, 99.9%, 20 nm, w/~0.3% PVP ) | 0478HW | 咨询 |
| Aluminum Powder (99.9%, 500 um) | 0156HW | 咨询 |
| Aluminum Powder (99.9%, 50 um) | 0154HW | 咨询 |
| Aluminum Powder (99.9%, 5 um) | 0152HW | 咨询 |
| Aluminum Nanoparticles (99.9%, 500 nm) | 0150HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 70-80 nm) | 0137HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 70-80 nm, w/PVP) | 0140HW | 咨询 |
| Aluminum Nanopowder (Al, 99.9+%, 40-50 nm) | 0138HW | 咨询 |
| Aluminum Nanopowder (99.9+%, 40-50 nm, w/PVP) | 0139HW | 咨询 |
| Aluminum Nanopowder (Al, 99+%, metal basis, 18 nm) | 0136JY | 咨询 |
| Gold (Au) Nanopowder (99.9%, 50-100 nm) | 0795CD | 咨询 |
| Gold (Au) Nanopowder (25nm, 99.9%) | 8801HW | 咨询 |
| Gold (Au) Nanopowder (10-20 nm, 99.95%) | 8796HW | 咨询 |
| Gold (Au) Nanopowder (10nm, 99.9%) | 8799HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.9%, 80-100 nm) | 0832HW | 咨询 |
| Bismuth Nanopowder (Bi, 99.5%, 40-60 nm) | 0831HW | 咨询 |
| Nano Activated Carbon (C, 88+%, 100 nm) | 1211NH | 咨询 |
| Diamond Nanopowder (synthesized, 55-70%, 4-15nm) | 1311JGY | 咨询 |
| Diamond Nanopowder (synthesized, 98+%, 3-10 nm) | 1321JGY | 咨询 |
| Diamond Nanopowder (synthesized, 97%, 3-6 nm) | 1350SL | 咨询 |
| Graphite Nanopowder (400 nm, 99.9%) | 1250HT | 咨询 |
| *Cobalt Nanopowder, Carbon Coated (Co, 99%, 40 nm) | 0286HW | 咨询 |
| *Cobalt Nanopowder (Passivated, 99.8%, 28 nm) | 0276JY | 咨询 |
| *Chromium Nanopowder (Cr, 99.5%, 50 nm) | 0240XX | 咨询 |
| *Copper Nanopowder (Cu, 99%, 500 nm) | 0293HW | 100g; |
| *Copper Nanopowder (Cu, 99.9%, 200 nm) | 0290HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 100 nm) | 0298HW | 25g; |
| *Copper Nanopowder (Partially Passivated, 99+%, 80 nm) | 0294HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 70 nm) | 0291HW | 25g; |
| *Copper Nanopowder (Cu, 99.5%, 50-80 nm) | 0292HW | 25g; |
| *Copper Nanopowder (Cu, 99.9%, 40 nm) | 0295HW | 25g; |
| *Copper Nanopowder (Cu, carbon coated, 99.8%, 25 nm) | 0297JY | 5g; |
| *Iron Nanopowder (Fe, 99.9%, 500nm) | 0272YM | 100g; 1kg; |
| *Iron Nanopowder (Fe, 99.9%, 100 nm) | 0264HW | 25g; |
| *Iron Nanopowder (Fe, 99.9%, 70 nm) | 0263HW | 25g; 100g; |
| *Iron Nanopowder (Fe, 99.9%, 40 nm) | 0262HW | 25g; 100g; |
| *Iron nanopowder, carbon coated (Fe/C, 99.6%, 25 nm) | 0267JY | 25g; |
| Germanium Nanopowder (Ge, 99.9+%, 600 nm) | 0327HW | 25g; |
| Germanium Nanopowder (Ge, 99.9%, 500 nm) | 0331HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 400 nm) | 0326HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 300 nm) | 0325HW | 1kg; |
| Germanium Nanopowder (Ge, 99.9+%, 200 nm) | 0323HW | 100g; kg; |
| Germanium Nanopowder (Ge, 99.9+%, 150 nm) | 0322HW | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, < 100 nm) | 0322HH | 咨询 |
| Germanium Nanopowder (Ge, 99.9+%, 20-50 nm) | 0321HW | 5g; |
| Iridium Nanopowder (Ir, 99.95%, 20-30 nm), wet powder in Deionized Water | 0771HW | 咨询 |
| *Molybdenum Nanopowder (Mo, 99.5%, 70 nm) | 0423HW | 咨询 |
| Niobium Nanopowder (Nb, 99.9%, 40-60 nm) | 0411HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 800 nm) | 0302HW | 咨询 |
| *Nickel Nanopowder (Ni, 99%, 400 nm) | 0301HW | 100g; 1kg; |
| *Nickel Nanopowder (Ni, 99+%, 300 nm) | 0289HW | 1kg; |
| *Nickel Nanopowder (Ni, 99.5%, 100 nm) | 0285HW | 25g; |
| *Nickel Nanopowder (Ni, 99.9%, 80 nm) | 0284HW | 300g; |
| *Nickel Nanopowder (Ni, 99.5%, 70 nm) | 0288HW | 25g; |
| *Nickel Nanopowder (Ni, 99.5%, 40 nm) | 0283HW | 25g; |
| *Nickel Nanopowder, carbon coated (Ni/C, 99.9%, 20 nm) | 0287JY | 5g; |
| Palladium Nanopowder (Pd, 99.95%, 20-30 nm) | 0462HW | 咨询 |
| Platinum Nanopowder (Pt, 99.95%, 20-30 nm) | 0782HW | 咨询 |
| Platinum Nanopowder, PVP coated (Pt, 99.95%, 20-30 nm) | 0787HW | 1g; |
| Platinum Nanopowder (Pt, 99.9%, 20-30 nm) | 0786HW | 1g; 5g; |
| Rhodium Nanopowder (Rh, 99.95%, 20-30 nm) | 0451HW | 咨询 |
| Ruthenium Nanopowder (Ru, 99.95%, 20-30 nm) | 0441HW | 1g; |
| *Silicon Nanopowder (Si, 99%, 400 nm) | 0144HW | 100g; |
| *Silicon Nanopowder (Si, 99.9%, 100 nm) | 0149HW | 100g; |
| *Silicon Nanopowder (Si, > 97%, 50 nm) | 0145KE | 咨询 |
| *Silicon Nanopowder (Si, 99%, 30-50 nm) | 0147HW | 50g; |
| *Silicon Nanopowder (Si, 98+%, 30-50 nm) | 0141JS | 50g; 100g; 500g; 1kg; |
| Tin Nanopowder (Sn, 70 nm, w/PVP ) | 5522HW | 500g; |
| Tin Nanopowder (Sn, 99.9%, 60-80 nm) | 0501HW | 咨询 |
| *Tantalum Nanopowder (Ta, 99.9%, 40 nm) | 0225HW | 25g; |
| *Tantalum Nanopowder (Ta, 99.9%, 70 nm) | 0224HW | 25g; |
| *Titanium Nanopowder (Ti, 99%, 60-80 nm) | 0227HW | 25g / $361; |
| *Tungsten Powder (W, 99.5+%, 1-2 um) | 0747HW | 100g; |
| *Tungsten Nanopowder (W, 99.5%, 500 nm) | 0749HW | 1kg; |
| *Tungsten Nanopowder (W, 99.5%, <100 nm) | 0745HW | 100g; |
| *Zinc Nanopowder (Zn, 99%, 500 nm) | 0318HW | 1kg; |
| *Zinc Nanopowder (Zn, 99.5%, 130 nm) | 0303HW | 25g; |
| *Zinc Nanopowder (Zn, 99.9+%, 100 nm) | 0306JY | 25g; |
| *Zinc Nanopowder (Zn, 99.5%, 80 nm) | 0304HW | 25g; |
| *Aluminum Nitride Nanopowder (AlN, Amorphous, <0.5um, 99.9%) | 1004HW | 咨询 |
| Aluminum Nitride Nanopowder (AlN, 99.9 %, 0.5 um) | 1005HW | 咨询 |
| *Aluminum Nitride Nanopowder (AlN, 99.5 %, 70-80 nm) | 1002HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 500 μm) | 1175HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 50 μm) | 1177HW | 咨询 |
| Boron Carbide Powder (B4C, 99%, 40 μm) | 1179HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 20μm) | 1172HW | 1kg; |
| Boron Carbide Powder (B4C, 98%, 10μm) | 1169HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 5 μm) | 1165HW | 1kg; |
| Boron Carbide Powder (B4C, 99%, 2 um) | 1183HW | 1 kg; |
| Boron Carbide Powder (B4C, 99+%, 1-2 μm) | 1162HW | 咨询 |
| Boron Carbide Nanopowder (B4C, 99+%, 500 nm) | 1160HW | 500g; |
| Boron Carbide Nanopowder (B4C, 99%, 50nm) | 1161HY | 100g; |
| Boron Nitride Powder (BN, hexagonal, 99.8%, 0.6-1.2um) | 1182HW | 咨询 |
| Boron Nitride Nanopowder (BN, hexagonal, 99%, 137 nm) | 1180YL | 25g; |
| Boron Nitride Nanoplates (BN, 99.5+%, 100 nm) | 1183NJ | 100g; |
| Chromium Carbide Nanopowder (Cr3C2, 99.9%, <100 nm) | 0247HW | 500g; 1kg; |
| Hafnium Boride Nanopowder (HfB2, 99+%, 60 nm) | 1010JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 200 nm) | 1005JC | 500g; |
| Hafnium Carbide Nanopowder (HfC, 99+%, 60 nm) | 1006JC | 100g; |
| Hafnium Carbide Nanopowder (HfC, 99%, 50nm) | 1022JC | kg; |
| Niobium Carbide Nanopowder (NbC, 99.9%, 500 nm) | 3860YM | 咨询 |
| Silicon Carbide Powder (SiC, 500 um, 99%, Hexagonal) | 4652HW | 1kg; ; |
| Silicon Carbide Powder (SiC, 50 um, 99%, Hexagonal) | 4654HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 40um, 99+%) | 4645HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 20um, 99+%) | 4643HW | 1kg; ; |
| Silicon Carbide Powder (SiC, Beta, 10um, 99+%) | 4641HW | 1kg; ; |
| Silicon Carbide Micron Powder (SiC, Beta, 7um, 99+%) | 4639HW | 100g; 1kg; ; |
| Silicon Carbide Powder (SiC, beta, 99.8%, 5 μm) | 4637HW | 100g; ; |
| Silicon Carbide Powder (SiC, beta, 99+%, 2 μm) | 4635HW | 咨询 |
| Silicon Carbide Powder (SiC, alpha, 99.9%, 2um) | 4627HY | 1kg; |
| Silicon Carbide Powder (SiC, 500 nm, 99%, Cubic) | 4656HW | 1kg; ; |
| Silicon Carbide Nanopowder (SiC, beta, 99%, 80-100 nm) | Stock # 4629HW | 100g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 55 nm) | 4625HY | 100g; |
| Silicon Carbide Nanopowder (SiC, beta, 97.5%, 45-55 nm) | 4620KE | 200g; |
| Silicon Carbide Nanopowder (SiC, alpha, 99.9%, 30 nm) | 4626HY | 100 g; 150 g; |
| Silicon Carbide Nanowhisker (beta, SiC, 99+%) | 4622HW | 25g; |
| Silicon Nitride Nanopowder (Si3N4, amorphous, 98.5+%, 15-30 nm) | 4750KE | 100g; |
| Titanium Boride Powder (TiB2, 2-12 μm ) | 5180HW | 100g |
| *Titanium Carbide Powder (TiC, 1 micron, 99%) | 5218YL | 500g; |
| *Titanium Carbide Nanoparticles (TiC, 100-200nm, 99+%) | 5217HW | 1kg; |
| Titanium Carbide (TiC, 99+%, 100 nm) | 5217JC | 100g; |
| *Titanium Carbide (TiC, 98+%, 80 nm) | 5220HT | 25g; 100g; |
| *Titanium Carbide Nanopowder (TiC, 97+%, 50 nm) | 5216KE | 100g; |
| *Titanium Nitride Powder (TiN, 99%, 1-3um) | 5352JC | 500g; 1kg; |
| *Titanium Nitride Nanoparticles (TiN, 99%, 100-200 nm) | 5357HW | 500g; |
| *Titanium Nitride Nanopowder (TiN, 97+%, 20 nm) | 5350KE | 100g; |
| Tungsten Carbide/Cobalt Nanopowder (8wt%Co/WC, < 200 nm, 99.5%) | 5561HW | 100g |
| Zirconium Carbide Nanopowder (ZrC, 99%, 8 um) | 5905KE | 100g; 250g; 500g; |
| *Zirconium Carbide Nanopowder (ZrC, 97%, 60 nm) | 5901KE | 100g; |
| *Zirconium Nitride Nanopowder (ZrN, 99.5%, 1-3um) | 6101JC | 500g; kg; |
| Zirconium Boride Nanopowder (ZrB2, 99%, 60 nm) | 5950JC | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 500 nm) | 1037HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99+%, 500 nm) | 1038HT | 100g; |
| Aluminum Oxide Nanopowder (alpha, aluminate coated, 98+%, 500 nm) | 1039HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 200 nm) | Stock #:1040LQS | 100g |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9%, 150 nm) | 1005MR | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha, 99.9+%, 40-50 nm) | 1044HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (alpha/theta, 99.99%, ~30nm ) | 1018WJ | 100g ; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99+%, 500 nm) | 1045HT | 100g; |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.97%, 20-30 nm) | 1020MR | 100g; 500g; 1kg; |
| Aluminum Oxide Nanopowder (gamma, 99.5%, 50 nm) | 1007XX | 咨询 |
| Aluminum Oxide (Al2O3) Nanopowder (gamma, 99.99%, 10 nm) | 1043HT | 100g; |
| Aluminum oxide nanopowder, (γ-phase) APS 20-30 nm, 99.95+% | 0125HW | 咨询 |
| Aluminum Oxide Nanopowder ( 99.99%, 30 nm ) for Lithium Batteries | 1016WJ | 咨询 |
| Aluminum Hydroxide Nanopowder (99.5 %, 50 nm) | 1040WJ | 咨询 |
| Boron Oxide Nanopowder (B2O3, 98%, 40-80 nm) | 1185DF | 咨询 |
| Boron Oxide Nanopowder (B2O3, 99%, 40-80 nm) | 1186DF | 1kg; |
| Bismuth Oxide Nanopowder (Bi2O3 , 99.9%, 100 nm) | 1171HT | kg; |
| Cerium Oxide, (CeO2, 99.99%, 200 nm) | 1445MG | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99%, 50-100 nm) | 1408HW | 100g; |
| Cerium Oxide (CeO2, 99.99%, 20-30 nm) | 1444ZQ | 100g; |
| Cerium Oxide Nanopowder (CeO2, 99.9%, 15-30 nm) | 1406RE | 100g; |
| Cobalt(II,III) Oxide Nanopowder (Co3O4, 99%, 50-80 nm) | 1720HT | 咨询 |
| Chromium Oxide Powder (Cr2O3, 99.8%, 1 um) | 1920FY | 25g; 1kg; |
| Chromium Oxide Powder (Cr2O3, 99.9%, 100 nm) | 1925FY | 100g; 1kg; |
| Chromium Oxide Nanopowder (Cr2O3, 99+%, 60 nm) | 1910FY | 25g; |
| Copper(II) Oxide Nanopowder (CuO, 99+%, 30-50 nm) | 2110FY | 咨询 |
| Copper(I) Oxide Nanopowder (Cu2O, 99%, 30-50 nm) | 2113HW | 25g; 100g; 500g; 1kg; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 55 nm) | 2252YS | 25g; |
| Dysprosium Oxide Nanopowder (Dy2O3, 99.9%, 30-70 nm) | 2253ZQ | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 43 nm) | 2310ZQ | 65g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 41-53 nm) | 2350YS | 25g; |
| Erbium Oxide Nanopowder (Er2O3, 99.9%, 20-30 nm) | 2330RE | 25g ; |
| Europium Oxide Nanopowder (Eu2O3, 99.995%, 58 nm) | 2410ZQ | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 45-58 nm) | 2450YS | 5g; |
| Europium Oxide Nanopowder (Eu2O3, 99.99%, 30-50 nm) | 2411RE | 5g; |
| Iron(III) Oxide Nanopowder (Fe2O3, gamma, 99.98%, 50 nm) | 2527YM | 1kg |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30-50 nm) | 2520ZH | 25g; 100g; |
| Iron(III) Oxide Nanopowder (Fe2O3, alpha, 99%, 30 nm) | 2525WJ | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 100-200 nm) | 2653HW | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 97%, 50-100 nm) | 2650TS | 100g; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, SSA: 9-14 m2/g, 50-100 nm) | 2655HW | 100g; 500g; 1kg; |
| Iron(II,III) Oxide Nanopowder (Fe3O4, 99%, 30 nm) | 2651WJ | 100g; |
| Iron Oxide Nanopowder (Fe3O4, PVP coated, 99+%, 20-30 nm) | 2657HW | 100g; 1kg; |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9+%, 20-80 nm) | 2680ZQ | 咨询 |
| Gadolinium Oxide Nanopowder (Gd2O3, 99.9%, 15-30 nm) | 2681RE | 咨询 |
| Hafnium Oxide Powder (HfO2, 99.99%, 48um) | 1045HW | 咨询 |
| Hafnium Oxide Powder (HfO2, 99%, 45um) | 1042HW | 咨询 |
| Indium Oxide Nanopowder (In2O3, 99.99%, 100-200 nm) | 2711TN | 咨询 |
| Indium Hydroxide Nanopowder (In(OH)3, 99.99%, 20-70 nm) | 2810TN | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99%, 50 nm) | 2922RE | 咨询 |
| Lanthanum Oxide Nanopowder (La2O3, 99.99%, 15-30 nm) | 2920RE | 咨询 |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40-60 nm) | 3305HT | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 1kg; |
| Magnesium Oxide Nanopowder (MgO, 99+%, 40 nm) | 3304HT | 咨询 |
| Magnesium Hydroxide Nanopowder (Mg(OH)2, 98+%, 100 nm) | 3321HT | 咨询 |
| Molybdenum(VI) Oxide Nanopowder (MoO3 , 99.5%, 100 nm) | 3851XW | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9+%, 83 nm) | 3910ZQ | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 49-64 nm) | 3950YS | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 40nm) | 3912RE | 咨询 |
| Neodymium Oxide Nanopowder (Nd2O3, 99.9%, 15-30 nm) | 3911RE | 25g; |
| Nickel Oxide Nanopowder (Ni2O3, 99.9%, 20-30 nm) | 4216HW | 100g; |
| Praseodymium Oxide Nanopowder (Pr6O11, 99.9%, 15-30 nm) | 4451RE | 25g; |
| Antimony Oxide Nanoparticles (Sb2O3, 99.99%, 20-30nm) | 6850HW | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.99%, 1-3.5 μm) | 4856WG | 咨询 |
| Silicon Oxide Powder (SiO2 , quartz, 99.998%, 1-3.5um) | 4855WG | 咨询 |
| Silicon Oxide Nanopowder (SiO2 , 99+%, 20 nm) | 4830HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4831HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4832HT | 咨询 |
| Silicon Oxide Nanopowder (99+%, 20 nm, hydrophilic & lipophilic) | 4833HT | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 42-55 nm) | 4950YS | 咨询 |
| Samarium Oxide Nanopowder (Sm2O3, 99.9%, 15-30 nm) | 4951RE | 咨询 |
| Titanium Oxide Nanopowder (TiO2, amorphous/anatase, 99+%, 5 nm) | 5416HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99%, 10-30 nm) | 5420HT | 咨询 |
| Titanium Oxide Nanopowder(TiO2, anatase, 99%,15 nm) | 5430MR | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 99+%, 10 nm) | 5417HT | 咨询 |
| Titanium Oxide Nanopowder (tungsten oxide doped, TiO2/WO3, anatase, 10 nm) | 5418HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase, 5 nm) | 5421ZH | 咨询 |
| Titanium Oxide Nanotubes (TiO2, anatase, 99%, 10-15 nm) | 5432HW | 咨询 |
| Titanium Oxide Nanopowder (TiO2, anatase/rutile, 99+%, 20 nm) | 5419HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 30 nm) | 5426HT | 咨询 |
| Titanium oxide (silica, alumina & stearic acid coated, anatase/rutile, 30 nm) | 5427HT | 咨询 |
| Titanium Oxide Nanopowder (silica, alumina & silicone oil coated, anatase/rutile, 30 nm) | 5428HT | 咨询 |
| Titanium oxide, silica coated (anatase/rutile, 20 nm) | 5422HT | 咨询 |
| Titanium oxide, silica & alumina coated (anatase/rutile, 20 nm) | 5423HT | 咨询 |
| Titanium oxide, silica & stearic acid coated (anatase/rutile, 20 nm) | 5424HT | 咨询 |
| Titanium oxide, silica & silicone oil coated (anatase/rutile, 20 nm) | 5425HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 500 nm) | 5429HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 150 nm) | 5430HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.9+%, 100 nm) | 5431HT | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 60 nm) | 5486WJ | 咨询 |
| Titanium Oxide Nanopowder (TiO2, rutile, 99.8%, 20-50 nm) | 5484WJ | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0302HT | 咨询 |
| Titanium Oxide (TiO2, rutile, coated with silicon oxide, 20 nm) | 0301HT | 咨询 |
| Vanadium Oxide Nanopowder (VO2, 99.9+%, 100 - 200 nm) | 5495HW | 咨询 |
| 1.5% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5499HW | 咨询 |
| 1% Tungsten-doped Vanadium Oxide Nanopowder (W-doped VO2, 99.9+%, 30 - 50 nm) | 5498HW | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.5%, 60-120 nm) | 5508YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99.9+%, 40-50 nm) | 5506BD | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm) | 5505YL | 咨询 |
| Tungsten Oxide Nanopowder (WO3, 99+%, 30-70 nm, PVP-coated) | 5506YL | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 50-70 nm) | 5610ZQ | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.99%, 20-40 nm) | 5611RE | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.9%, 32-36 nm) | 5650YS | 咨询 |
| Yttrium Oxide Nanopowder (Y2O3, 99.995%, 20-40 nm) | 5611ZQ | 咨询 |
| Ytterbium Oxide Nanopowder (Yb2O3, 10-80 nm, 99.9%) | 5671RE | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99+%, 800 nm) | 5816HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 30 nm) | 5811HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, hydrophilic & lipophilic) | 5812HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, silicone oil coated) | 5814HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 98+%, 30 nm, stearic acid coated) | 5815HT | 咨询 |
| Zinc Oxide Nanopowder (ZnO, 99%, 20 nm) | 5810HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99+%, 50 nm) | 5936HT | 咨询 |
| Zirconium Oxide Nanopowder (ZrO2, 99.5+%, 20 nm) | 5931HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/3 mol% Y2O3, 99.5+%, 15-50 nm) | 5932HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/5 mol% Y2O3, 99.5+%, 15-50 nm) | 5934HT | 咨询 |
| Zirconia Nanopowder, Yttria Doped (ZrO2/8 mol% Y2O3, 99.5+%, 15-50 nm) | 5933HT | 咨询 |
| Zirconia Nanopowder, Calcia Doped (ZrO2/8 mol%CaO, 99.9%, 20-30 nm) | 5934ZS | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 400 nm) | 1146DY | 100g; |
| Barium Titanate Nanopowder (BaTiO3 , 99.9%, 300 nm) | 1144DY | 咨询 |
| Barium Titanate Nanopowder (BaTiO3 , 99.5%, 100-200 nm) | 1148DY | 咨询 |
| Cobalt Iron Oxides Nanopowder (CoFe2O4, 98%, 35-55 nm) | 1510FY | 25g ; 100g; |
| Cobalt-Zinc Iron Oxide Nanopowder (Co0.5Zn0.5Fe2O4, 99.5%, 30-50 nm) | 1515FY | 25g ; 100g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 90wt%:10wt%, 99.99%, 20-70 nm) | 2730TN | 5g; 25g; |
| Indium Tin Oxide Nanopowder (In2O3:SnO2 = 95 wt%:5 wt%, 99.99%, 30-50 nm) | 2731BY | 5g; 25g; |
| Nickel-Zinc Iron Oxide Nanopowder (Ni0.5Zn0.5Fe2O4, 98.5%, 10-30 nm) | 4115FY | 100g; 500g; |
| *Ni80Fe17Mo3 permalloy nanopowder (99+%, 70 nm) | 9288HW | 100g; |
| Yttrium Aluminate w/Nd doped (Y2.98Nd0.02Al5O12, Nd-YAG, 99.5%, 40 nm) | 5571FY | 25g; 100g; |
| Zinc Iron Oxide Nanopowder (ZnFe2O4, 98.5%, 40 nm) | 5710FY | 100g; |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理HycultBiotech全系列产品。
Hycult Biotech是一家专注于设计、研发、生产以及销售抗体和其相关产品的公司,其特色产品是天然免疫及相关领域的免疫分析试剂,例如补体, 嗜中性粒细胞蛋白,TLP,清道夫受体以及急性期蛋白等。除此之外,Hycult Biotech公司也可以提供炎症反应和细胞损伤等方面的产品。
HYCULT BIOTECH的主要产品包括:
Assays
Monoclonal antibodies
Polyclonal antibodies
Disease state human plasma
Proteins
Functional study antibodies
Immunoassay antibodies
Secondary reagents
按照产品领域细分:
Acute phase proteins
Adhesion molecules
Antimicrobial peptides
Cell damage and toxicity
Coagulation molecules
Complement and collectins
Cytokines and chemokines
Granulocyte and lymphocyte proteins
LPS and microbial toxins
Oxidative stress
TLR and inflammasome
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Hycult Biotech"> Hycult Biotech
VWR作为全球领先的科学技术服务供应商,长期致力于在制药、生物技术、工业、教育、政府和医疗保健领域为实验室和量产客户提供优质产品、服务和解决方案。VWR has long been the leading global, independent provider of product and service solutions to laboratory and production customers, enabling science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries.
VWR的主要产品包括:
VWR Equipment and Instrumentation
All You Need for Analytical Chemistry
Centrifugation
Chemicals
Chromatography (R&D)
Cold Storage
Electrochemistry
Life Science
Liquid Handling
Microscopy
Ovens & Incubators
Organic Synthesis at VWR
Safety
Spectrophotometers
Temperature Measurement & Thermometers
Titration
Weighing
R&D Literature
Beckman Coulter
ELGA
Heidolph
Kimble
METTLER TOLEDO
Molecular Devices
Pall Laboratory
Panasonic Healthcare Corporation of North America
WHEATON
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="VWR"> VWR
艾美捷科技代理Cali-Bio品牌。
Cali-Bio成立于 2009 年,总部位于美国加利福尼亚州,是一家专注于为生命科学研究和生物制药行业提供高质量试剂、细胞培养工具和相关服务的公司。Cali-Bio公司专注于开发和生产高质量的生物试剂和细胞培养工具,产品涵盖细胞培养基、血清、生长因子、细胞分离试剂和定制服务等。Cali-Bio 的产品被广泛应用于细胞生物学、免疫学、癌症研究、干细胞研究和生物制药等领域。Cali-Bio公司主要产品包括:
(1)细胞培养基
经典培养基,提供 DMEM、RPMI-1640、MEM 等常用培养基。
无血清培养基,适用于特定细胞类型的无血清培养,减少批次间差异。
干细胞培养基,支持干细胞的自我更新和分化。
(2)血清和补充剂
胎牛血清(FBS),高质量胎牛血清,适用于多种细胞培养。
马血清、人血清,用于特定细胞类型的培养。
生长因子和细胞因子,包括 EGF、FGF、IGF 等,支持细胞生长和功能维持。
(3)细胞分离和传代试剂
胰酶和细胞解离试剂,用于细胞传代和单细胞分离。
细胞冻存液,提供高效的细胞冻存解决方案,确保细胞存活率。
(4)细胞检测和分析工具
细胞活力检测试剂,如 MTT、CCK-8 等,用于评估细胞活力和增殖。
细胞凋亡检测试剂,用于检测细胞凋亡和坏死。
细胞迁移和侵袭实验试剂,支持癌症研究和药物筛选。

艾美捷科技有限公司代理Mimotopes公司多肽及多肽合成相关产品。Mimotopes公司位于澳大利亚,可以提供2000余种多肽,100余种药物及化妆品肽,1000余种各类氨基酸及多肽合成用试剂。
Mimotopes公司的主要产品类别:
(1)多肽(Peptides)
库存普通多肽(Catalogue Peptides)
化妆品肽(Cosmetic Peptides)
药物肽(Pharmaceutical Peptides)
肽库(Off-the-Shelf Library)
(2)氨基酸(Amino Acids)
Z Amino Acids
Unusual Amino Acids
N methyl Amino Acids
Fmoc Amino Acids
Common Amino Acids
Boc amino acids
AA attached_to_2-Chlorotrityl_Resin
AA attached_to_Wang_Resin
(3)多肽合成试剂(Peptides Synthesis Reagents)
Coupling Reagents
Amino Alcohols
General Reagents
Linkers
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
< " data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Mimotopes"> Mimotopes
<艾美捷科技有限公司代理Echelon Biosciences的产品:
http://www.amyjet.com/Index/lists/catid/27/kid/57.html
Echelon Biosciences成立于1997年,致力于为脂质研究领域提供高品质的检测方法和检测试剂。
Echelon Biosciences Incorporated (EBI) was incorporated under the laws of the state of Utah as Echelon Research Laboratories, Inc. on October 3, 1997. Initially, EBI was formed from a project under the Center for Cell Signaling, a State of Utah Center of Excellence, with the aim to further the science of lipid cell signaling and critical metabolic enzymes, which provide new and viable targets for the development of potential drugs and diagnostics for cancer, diabetes, inflammation, infections, and cardiovascular disease.
Echelon Bioscience的产品和服务包括:
| (2S)-Oleyl LPA (Echelon Bioscience, CAT#L-0186) |
| (E,E,E)-Geranylgeraniol (Echelon Bioscience, CAT#S-0200) |
| (E,E)-Farnesoic acid (Echelon Bioscience, CAT#S-0151) |
| (E,E)-Methyl Farnesoate (Echelon Bioscience, CAT#S-0153) |
| (S,S) Bisoleoyl-lysobisphosphatidic acid (LBPA) (Echelon Bioscience, CAT#L-B181) |
| (S)-FTY720 Phosphate (Echelon Bioscience, CAT#B-0721) |
| [4-(Decanoylamino)benzyl]phosphonic acid (GWJ-23, GWJ-A-23) (Echelon Bioscience, CAT#L-3223) |
| [D-Ala2]-Deltorphin II (Echelon Bioscience, CAT#275-21) |
| [Hyp3]-Bradykinin (Echelon Bioscience, CAT#191-65) |
| [Ser25] Protein Kinase C Substrate (19-31) (Echelon Bioscience, CAT#871-21) |
| 1-Deoxy-D-xylulose (DX) (Echelon Bioscience, CAT#I-M050A) |
| 1-Deoxy-D-xylulose 5-phosphate (DXP) (Echelon Bioscience, CAT#I-M050) |
| 1-Hydroxy-2-methyl-2-buten-4-yl 4-diphosphate (HDMAPP) (Echelon Bioscience, CAT#I-M055) |
| 1-Methylhistamine dihydrochloride (Echelon Bioscience, CAT#B-0032) |
| 1-Naphthalenesulfonyl-Ile-Trp-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-76) |
| 1-Stearoyl-2-Arachidonoyl-sn-Glycerol (Echelon Bioscience, CAT#L-0024) |
| 1,2-Distearoyl-sn-glycerol (Echelon Bioscience, CAT#L-0018) |
| 1,3-DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2216) |
| 1,3-POPE (16:0/18:1 PE) (Echelon Bioscience, CAT#L-2368) |
| 16:0 LPE (Echelon Bioscience, CAT#L-2516) |
| 16:0 LPG (Echelon Bioscience, CAT#L-5216) |
| 16:0 LPThr (Echelon Bioscience, CAT#L-3316) |
| 18:1 LysoPEth (Echelon Bioscience, CAT#L-6030) |
| 18:2 LysoPC (Echelon Bioscience, CAT#L-1520) |
| 1D-O-(1,2-Di-O-oleoyl-sn-(2S)-glycerol-3-phospho)-3-(phosphothionate)-myo-inositol (Echelon Bioscience, CAT#P-3S18) |
| 1R,2R-B13 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0042) |
| 2-Acetyl-5-tetrahydroxybutyl imidazole (THI) (Echelon Bioscience, CAT#B-0031) |
| 2-C-Methyl-D-erythritol 2,4-cyclophosphate (Echelon Bioscience, CAT#I-M054) |
| 2-C-Methyl-D-erythritol 4-phosphate (MEP) (Echelon Bioscience, CAT#I-M051) |
| 2-C-Methyl-erythritol (ME) (Echelon Bioscience, CAT#I-M051A) |
| 2-Furoyl-LIGR-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-12) |
| 2-Furoyl-LIGRL-Amide (Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-11) |
| 2-Furoyl-LIGRLO-NH2 (Potent and Selective Protease-Activated Receptor 2 (PAR2) Agonist) (Echelon Bioscience, CAT#873-10) |
| 2-O-Butyryl-Ins(1,3,4,5,6)P5/PM (Echelon Bioscience, CAT#Q-M1396) |
| 2,3-Oxidosqualene (racemic) (Echelon Bioscience, CAT#S-0301) |
| 2,3,22,23-Dioxidosqualene (Echelon Bioscience, CAT#S-0302) |
| 2,3,5-Tri-O-butyryl-Ins(1,4,6)P3/AM (Echelon Bioscience, CAT#Q-M0146) |
| 2S-OMPT (Echelon Bioscience, CAT#L-9418) |
| 2Z,6Z-Farnesol (Echelon Bioscience, CAT#S-0170) |
| 2Z,6Z-Farnesyl Diphosphate (Echelon Bioscience, CAT#I-0170) |
| 3-a-Aminocholestane (3AC, SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0341) |
| 3,3′-Bisoleoyl-LBPA tetrabutylammonium salt (Echelon Bioscience, CAT#L-B182) |
| 3C-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3C916) |
| 3C-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3C908) |
| 3S-PtdIns(3,4,5)P3, diC16 (Echelon Bioscience, CAT#P-3S916) |
| 3S-PtdIns(3,4,5)P3, diC8 (Echelon Bioscience, CAT#P-3S908) |
| 4-Demethylaminosancycline (CMT-3) (Echelon Bioscience, CAT#B-0802) |
| 4-Diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) (Echelon Bioscience, CAT#I-M052) |
| 4-Methylumbelliferone (Echelon Bioscience, CAT#JK201388) |
| 5-Ketoclomazone (DXP Synthase Inhibitor) (Echelon Bioscience, CAT#B-4101) |
| 5′ PtdIns(3,4,5)P3 Phosphatase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1400) |
| 6-O-palmitoyl-L-ascorbic acid (HAse Inhibitor) (Echelon Bioscience, CAT#B-0601) |
| 7-azido-4-methylcoumarin (AzMC, Hydrogen sulfide detector) (Echelon Bioscience, CAT#D-0010) |
| 9-tert-Butyl Doxycycline HCl (Echelon Bioscience, CAT#B-0801) |
| 9(10)-Nitrooleic Acid (Echelon Bioscience, CAT#L-0112) |
| 9Z-Octadecenyl phosphate (Echelon Bioscience, CAT#L-0418) |
| a-Secretase Substrate (Echelon Bioscience, CAT#640-55) |
| ABC294640 (SPHK2 Inhibitor) (Echelon Bioscience, CAT#B-0025) |
| Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate) (Echelon Bioscience, CAT#855-46) |
| Ac-Ala-Arg-AMC (Echelon Bioscience, CAT#877-13) |
| Ac-Ala-Glu-Val-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-65) |
| Ac-Ala-Glu-Val-Asp-CHO (Caspase 3 Inhibitor) (Echelon Bioscience, CAT#864-65) |
| Ac-Ala-Glu-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-65) |
| Ac-Arg-Ala-Arg-AMC (Echelon Bioscience, CAT#855-71) |
| Ac-Arg-Ala-Val-AMC (Echelon Bioscience, CAT#877-08) |
| Ac-Arg-Gly-Phe-Phe-Pro-AFC (Cathepsin D Substrate, fluorogenic) (Echelon Bioscience, CAT#874-19) |
| Ac-Arg-Gly-Phe-Phe-Pro-AMC (Echelon Bioscience, CAT#877-06) |
| Ac-Arg-Leu-Arg-AMC (Echelon Bioscience, CAT#920-75) |
| Ac-Arg-Ser-Leu-Lys-AMC (Site 1 Protease Substrate, fluorogenic) (Echelon Bioscience, CAT#877-09) |
| Ac-Asp-Gln-Met-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#863-26) |
| Ac-Asp-Gln-Met-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-22) |
| Ac-Asp-Glu-Val-Asp-4MbNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#861-18) |
| Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-18) |
| Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-20) |
| Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-30) |
| Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-28) |
| Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#860-25) |
| Ac-DEVD-AFC, (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-17) |
| Ac-DEVD-CHO, Caspase 3 (Apopain) Inhibitor (Echelon Bioscience, CAT#864-20) |
| Ac-Glu-Ser-Met-Asp-AFC (Procaspase 3 Substrate, fluorogenic) (Echelon Bioscience, CAT#880-22) |
| Ac-Glu-Ser-Met-Asp-CHO (Procaspase 3 Inhibitor) (Echelon Bioscience, CAT#864-22) |
| Ac-Glu-Val-Asn-Leu-AMC (Echelon Bioscience, CAT#877-11) |
| Ac-Glu-Val-Asn-Leu-pNA (Echelon Bioscience, CAT#876-06) |
| Ac-Ile-Gln-Ala-Cys-Arg-Gly-OH (Caspase Active Site Peptide) (Echelon Bioscience, CAT#866-12) |
| Ac-Ile-Glu-Pro-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-30) |
| Ac-Ile-Glu-Pro-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-69) |
| Ac-Ile-Glu-Pro-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#865-30) |
| Ac-Ile-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-58) |
| Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate) (Echelon Bioscience, CAT#860-58) |
| Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II) (Echelon Bioscience, CAT#860-59) |
| Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-56) |
| Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate) (Echelon Bioscience, CAT#860-43) |
| Ac-Leu-Glu-Glu-Asp-AFC (Caspase 13 Substrate) (Echelon Bioscience, CAT#863-55) |
| Ac-Leu-Glu-Glu-Asp-AMC (Caspase 13 Substrate) (Echelon Bioscience, CAT#862-55) |
| Ac-Leu-Glu-Glu-Asp-CHO (Caspase 13 Inhibitor) (Echelon Bioscience, CAT#864-85) |
| Ac-Leu-Glu-Glu-Asp-pNA (Caspase 13 Substrate) (Echelon Bioscience, CAT#861-85) |
| Ac-Leu-Glu-His-Asp-AFC (Caspase 9 Substrate) (Echelon Bioscience, CAT#863-40) |
| Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-45) |
| Ac-Leu-Glu-His-Asp-CHO (Caspase 9 Inhibitor) (Echelon Bioscience, CAT#864-45) |
| Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate) (Echelon Bioscience, CAT#860-47) |
| Ac-Leu-Glu-Thr-Asp-AFC (Caspase 8 Substrate) (Echelon Bioscience, CAT#863-44) |
| Ac-Leu-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor) (Echelon Bioscience, CAT#864-44) |
| Ac-Leu-Glu-Val-Asp-AFC (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#863-42) |
| Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate) (Echelon Bioscience, CAT#860-49) |
| Ac-Leu-Glu-Val-Asp-CHO (Caspase 4 (ICH-2) Inhibitor) (Echelon Bioscience, CAT#864-42) |
| Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate) (Echelon Bioscience, CAT#860-42) |
| Ac-Leu-Leu-Arg-AMC (Echelon Bioscience, CAT#877-12) |
| Ac-Leu-Leu-Tyr-AFC (Echelon Bioscience, CAT#875-20) |
| Ac-Leu-Val-Lys-CHO (Cathepsin B Inhibitor II) (Echelon Bioscience, CAT#866-39) |
| Ac-Lys-Gln-Lys-Leu-Arg-4-methoxy-2-naphthylamide (Echelon Bioscience, CAT#878-02) |
| Ac-Lys-Pro-Arg-AMC (Echelon Bioscience, CAT#877-07) |
| Ac-Orn-Phe-Arg-AMC (Tryptase Substrate, fluorogenic) (Echelon Bioscience, CAT#871-94) |
| Ac-Phe-Ser-Arg-pNA (Echelon Bioscience, CAT#876-01) |
| Ac-Thr-Gln-Thr-Asp-AFC (DRONC Substrate) (Echelon Bioscience, CAT#850-16) |
| Ac-Thr-Gln-Thr-Glu-AFC (DRONC Substrate I) (Echelon Bioscience, CAT#850-17) |
| Ac-Trp-Glu-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-61) |
| Ac-Trp-Glu-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-63) |
| Ac-Trp-Glu-His-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#863-63) |
| Ac-Trp-Glu-His-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-60) |
| Ac-Trp-Glu-His-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-66) |
| Ac-Trp-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-64) |
| Ac-Trp-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-66) |
| Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-41) |
| Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-17) |
| Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-16) |
| Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-15) |
| Ac-Val-Ala-Asp-4MbNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#863-12) |
| Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-12) |
| Ac-Val-Ala-Asp-CHO (Caspase 1 (ICE) Inhibitor) (Echelon Bioscience, CAT#864-12) |
| Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate) (Echelon Bioscience, CAT#860-11) |
| Ac-Val-Asn-Leu-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-70) |
| Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-44) |
| Ac-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-48) |
| Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-48) |
| Ac-Val-Asp-Val-Ala-Asp-CHO (Caspase 2 (ICH-1) Inhibitor) (Echelon Bioscience, CAT#864-46) |
| Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#860-46) |
| Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate) (Echelon Bioscience, CAT#860-54) |
| Ac-Val-Glu-His-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-74) |
| Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-52) |
| Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor) (Echelon Bioscience, CAT#860-57) |
| Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#860-50) |
| Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate) (Echelon Bioscience, CAT#860-26) |
| Ac-Val-Lys-Met-Asp-AFC (Caspase Substrate) (Echelon Bioscience, CAT#863-72) |
| Ac-VEID-AFC (Caspase 6 (Mch2) Substrate) (Echelon Bioscience, CAT#863-52) |
| Ac-YVAD-CHO, Caspase 1 (ICE) Inhibitor (Echelon Bioscience, CAT#864-15) |
| Acetyl Calcitonin, salmon (Echelon Bioscience, CAT#237-36) |
| Acetyl-Beta Amyloid (25-35) (Echelon Bioscience, CAT#641-59) |
| Acetyl-Neurotensin (8-13) (Echelon Bioscience, CAT#631-41) |
| Acid Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-3200) |
| ACTH (1-17), human (Echelon Bioscience, CAT#111-75) |
| ACTH (1-24), human (Echelon Bioscience, CAT#111-36) |
| ACTH (1-39), rat (Echelon Bioscience, CAT#115-10) |
| ACTH (7-38), human / Corticotropin Inhibiting Peptide (7-38), human (Echelon Bioscience, CAT#111-45) |
| Activity Dependant Neuroprotective Protein (74-81) (mouse, rat) (Echelon Bioscience, CAT#878-03) |
| ADAM substrate (Echelon Bioscience, CAT#825-15) |
| Adamantaneacetyl-Bradykinin [DArg0,Hyp3,Thi5,8,DPhe7] (Echelon Bioscience, CAT#191-84) |
| Adrenal Secretogranin, bovine (Echelon Bioscience, CAT#313-20) |
| Adrenomedullin (1-50), rat (Echelon Bioscience, CAT#335-75) |
| Adrenomedullin (1-52), human (Echelon Bioscience, CAT#331-80) |
| Adrenomedullin (11-50), rat (Echelon Bioscience, CAT#335-80) |
| Adrenomedullin (22-52), human (Echelon Bioscience, CAT#331-82) |
| Agatoxin IVa ( SS Cys 4,20 / Cys 12,25 / Cys 19,36 / Cys 27 (Echelon Bioscience, CAT#429-15) |
| Akt Substrate (Echelon Bioscience, CAT#868-15) |
| Alkyl-OMPT (Echelon Bioscience, CAT#L-9518) |
| Allatostatin B2, cockroach (Echelon Bioscience, CAT#781-20) |
| Alpha MSH [D-Phe7] (Echelon Bioscience, CAT#570-42) |
| Alpha MSH [Nle4,D-Phe7] (Echelon Bioscience, CAT#570-43) |
| Alpha MSH, Ac-NLe4c[Asp5,DNal7,Lys10](4-10) amide (Echelon Bioscience, CAT#571-49) |
| AMARA peptide substrate (Echelon Bioscience, CAT#890-23) |
| Aminocardiolipin (Amino-CL) (Echelon Bioscience, CAT#L-C16A) |
| Amylin (1-37), human, amide (Echelon Bioscience, CAT#641-50) |
| Amyloid Blocker (Echelon Bioscience, CAT#641-81) |
| Amyloid Fragment (Pro18,Asp21) (17-21) (Echelon Bioscience, CAT#641-64) |
| Angiotensin (1-5) (Echelon Bioscience, CAT#131-53) |
| Angiotensin (1-7) (Echelon Bioscience, CAT#131-41) |
| Angiotensin I (1-9), DRVYIHPFH-OH (Echelon Bioscience, CAT#131-55) |
| Angiotensin I (human) (Echelon Bioscience, CAT#131-25) |
| Angiotensin I [Asn1,Val5,Asn9], salmon (Echelon Bioscience, CAT#137-40) |
| Angiotensin I [Asn1,Val5], goosefish (Echelon Bioscience, CAT#137-39) |
| Angiotensin I [Val5,Asn9], bullfrog (Echelon Bioscience, CAT#137-36) |
| Angiotensin II Antipeptide (Echelon Bioscience, CAT#131-64) |
| Angiotensin II-[Sar1] (Echelon Bioscience, CAT#131-65) |
| Angiotensin II, human (Echelon Bioscience, CAT#131-49) |
| Angiotensin III, human / Angiotensin II-[Des Asp1] (Echelon Bioscience, CAT#131-76) |
| Angiotensinogen (1-14) Renin Substrate, porcine (Echelon Bioscience, CAT#131-82) |
| Anti human Vps34 Antibody (Echelon Bioscience, CAT#Z-R016) |
| Anti-hVps34 Antibody for IP (Echelon Bioscience, CAT#Z-R015) |
| Anti-PEth Autologous IgG ELISA (Echelon Bioscience, CAT#K-5000A) |
| Anti-PtdIns(3,4,5)P3 IgM HRP (Echelon Bioscience, CAT#Z-H345) |
| Anti-PtdIns(3,4,5)P3 IgM In Ascities (Echelon Bioscience, CAT#Z-A345) |
| Anti-PtdIns(4,5)P2 IgM In Ascites (Echelon Bioscience, CAT#Z-A045) |
| Anti-Rat F1-ATP Synthase Alpha Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPA) |
| Anti-Rat F1-ATP Synthase Beta Subunit Rabbit Polyclonal Antibody (Echelon Bioscience, CAT#Z-RATPB) |
| Antibody Sample Pack (Echelon Bioscience, CAT#Z-P100) |
| AP-811 (NPR-C receptor ligand) (Echelon Bioscience, CAT#492-10) |
| Apamin, bee venom (SS1-11, SS3-15) (Echelon Bioscience, CAT#425-10) |
| APP Beta Secretase Inhibitor (Echelon Bioscience, CAT#649-10) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-22) |
| APP Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-23) |
| Arachidonoyl LPA, 20:4 LPA (Echelon Bioscience, CAT#L-0204) |
| Arachidoyl LPA, 20:0 LPA (Echelon Bioscience, CAT#L-0200) |
| Arg-Gly-Asp-Ser (RGDS) (Echelon Bioscience, CAT#450-29) |
| ARN14988 (aCDase Inhibitor) (Echelon Bioscience, CAT#B-0041) |
| AS1938909 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0343) |
| AS1949490 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0342) |
| AS604850 (PI3-K gamma Inhibitor 2) (Echelon Bioscience, CAT#B-0302) |
| AS605240 (PI3-K gamma Inhibitor 1) (Echelon Bioscience, CAT#B-0301) |
| Atrial Natriuretic Peptide (1-28), human / ANP (1-28), human (Echelon Bioscience, CAT#151-25) |
| Atrial Natriuretic Peptide (1-28), rat (Echelon Bioscience, CAT#155-56) |
| Atrial Natriuretic Peptide (4-28), rat / Auriculin B (Echelon Bioscience, CAT#155-62) |
| Atrial Natriuretic Peptide (ANP) (4-24), frog (Echelon Bioscience, CAT#153-15) |
| Atrial Natriuretic Peptide (ANP) Des[18-22] (4-23) amide, rat (Echelon Bioscience, CAT#155-40) |
| Atriopeptin III, rat [ANP (127-150), rat] (Echelon Bioscience, CAT#155-63) |
| ATX Sandwich ELISA Assay Service (Echelon Bioscience, CAT#T-5600) |
| ATX-Red AR-2 (Echelon Bioscience, CAT#L-2010) |
| Autocamptide-2 Related Inhibitoy Peptide (Echelon Bioscience, CAT#891-24) |
| Autocamtide-2 Related Inhibitory Peptide, myristoylated (Echelon Bioscience, CAT#891-26) |
| Autotaxin Activity Assay (Echelon Bioscience, CAT#K-4100) |
| Autotaxin Activity Assay Service (Echelon Bioscience, CAT#T-4100) |
| Autotaxin Enzyme, active (Echelon Bioscience, CAT#E-4000) |
| Autotaxin Inhibitor Screening Assay Service (Echelon Bioscience, CAT#T-4200) |
| Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200) |
| Autotaxin Sandwich ELISA Kit (Echelon Bioscience, CAT#K-5600) |
| BAM (6-22) Bovine Adrenal Medulla Peptide (6-22) (Echelon Bioscience, CAT#313-64) |
| BAM 3200 Bovine Adrenal Medulla Peptide E (Echelon Bioscience, CAT#313-65) |
| Benzo[a]pyrene (Echelon Bioscience, CAT#B-0050) |
| Beta Amyloid (25-35), human (Echelon Bioscience, CAT#641-40) |
| Beta Amyloid [Glu11] (10-16), human (Echelon Bioscience, CAT#641-45) |
| Beta Amyloid [Nle35] (1-40), human (Echelon Bioscience, CAT#641-13) |
| Beta Amyloid (1-16) [Gln11], human (Echelon Bioscience, CAT#641-35) |
| Beta Amyloid (1-16), rat (Echelon Bioscience, CAT#642-36) |
| Beta Amyloid (1-28), [Gln11], human (Echelon Bioscience, CAT#641-17) |
| Beta Amyloid (1-28), rat (Echelon Bioscience, CAT#642-18) |
| Beta Amyloid (1-40), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-14) |
| Beta Amyloid (1-40), rat (Echelon Bioscience, CAT#642-10) |
| Beta Amyloid (1-42), human (Echelon Bioscience, CAT#641-15) |
| Beta Amyloid (1-42), human – HFIP (Echelon Bioscience, CAT#641-00) |
| Beta Amyloid (1-42), human (Arctic) [Gly22] (Echelon Bioscience, CAT#641-22) |
| Beta Amyloid (1-42), rat (Echelon Bioscience, CAT#642-15) |
| Beta Amyloid (10-20), human (Echelon Bioscience, CAT#641-21) |
| Beta Amyloid (12-28), human (Echelon Bioscience, CAT#641-19) |
| Beta Amyloid (13-16), human (Echelon Bioscience, CAT#641-88) |
| Beta Amyloid (16-10), reverse, human (Echelon Bioscience, CAT#641-54) |
| Beta Amyloid (17-42), human (Echelon Bioscience, CAT#641-90) |
| Beta Amyloid (22-35), human (Echelon Bioscience, CAT#641-44) |
| Beta Amyloid (25-35) [Ala28] (Echelon Bioscience, CAT#640-19) |
| Beta Amyloid (25-35) [Gly35] (Echelon Bioscience, CAT#640-21) |
| Beta Amyloid (25-35) [Nle35], human (Echelon Bioscience, CAT#641-53) |
| Beta Amyloid (26-35), human (Echelon Bioscience, CAT#641-41) |
| Beta Amyloid (27-35), human (Echelon Bioscience, CAT#641-42) |
| Beta Amyloid (28-35), human (Echelon Bioscience, CAT#641-43) |
| Beta Amyloid (35-25), reverse, human (Echelon Bioscience, CAT#641-47) |
| Beta Amyloid (40-1), reverse, human (Echelon Bioscience, CAT#641-70) |
| Beta Amyloid (42-1) reverse, human (Echelon Bioscience, CAT#641-69) |
| Beta Amyloid [Gln 22] (1-40), human (Echelon Bioscience, CAT#640-20) |
| Beta Amyloid [Gln 22] (1-42), human (Echelon Bioscience, CAT#642-30) |
| Beta Amyloid [Gln11] (1-40) , human (Echelon Bioscience, CAT#641-11) |
| Beta Amyloid [Glp3] (3-42), human (Echelon Bioscience, CAT#641-16) |
| Beta Amyloid [Glu11] (1-16) (Echelon Bioscience, CAT#641-36) |
| Beta Amyloid [Glu11] (1-38), human (Echelon Bioscience, CAT#641-25) |
| Beta Amyloid [Glu11] (1-40), human (Echelon Bioscience, CAT#641-10) |
| Beta Amyloid [Glu11] (1-40), human – HFIP (Echelon Bioscience, CAT#641-01) |
| Beta Amyloid [Glu11], (1-28), human (Echelon Bioscience, CAT#641-18) |
| Beta Endorphin, human / Beta Lipotropin (61-91), human (Echelon Bioscience, CAT#291-25) |
| Beta MSH, human (Echelon Bioscience, CAT#571-47) |
| Beta Secretase Inhibitor II (Echelon Bioscience, CAT#649-18) |
| Big Endothelin (1-38), human (Echelon Bioscience, CAT#331-30) |
| Big Endothelin (1-39), porcine (Echelon Bioscience, CAT#334-10) |
| Big Endothelin (1-39), rat (Echelon Bioscience, CAT#335-50) |
| Big Endothelin 1 [D-Val22] (16-38), human (Echelon Bioscience, CAT#331-32) |
| Big Endothelin 2 (1-37), human (Echelon Bioscience, CAT#331-40) |
| Big Gastrin, sulfated (Echelon Bioscience, CAT#471-80) |
| Bilirubin (Echelon Bioscience, CAT#F-H120) |
| Bilirubin Conjugate (Echelon Bioscience, CAT#F-H130) |
| Bilirubin dimethyl ester (Echelon Bioscience, CAT#F-H110) |
| Biliverdin Hydrochloride (Echelon Bioscience, CAT#F-H100) |
| Biotin 18:0 LysoPC (Echelon Bioscience, CAT#L-15B18) |
| Biotin Monolysocardiolipin (Echelon Bioscience, CAT#L-M16B) |
| Biotin Phosphatidylinositol (Echelon Bioscience, CAT#C-00B6) |
| Biotin Phosphatidylinositol 3-phosphate (Echelon Bioscience, CAT#C-03B6) |
| Biotin Phosphatidylinositol 3,4-bisphosphate (Echelon Bioscience, CAT#C-34B6) |
| Biotin Phosphatidylinositol 3,5-bisphosphate (Echelon Bioscience, CAT#C-35B6) |
| Biotin Phosphatidylinositol 4-phosphate (Echelon Bioscience, CAT#C-04B6) |
| Biotin Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45B6) |
| Biotin Phosphatidylinositol 5-phosphate (Echelon Bioscience, CAT#C-05B6) |
| Biotin PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6) |
| Biotin Sphingomyelin (Echelon Bioscience, CAT#S-400B) |
| biotin-C12-ether LBPA (Echelon Bioscience, CAT#L-B1B12) |
| Biotin-Cardiolipin (Echelon Bioscience, CAT#L-C16B) |
| Biotin-Ceramide (Echelon Bioscience, CAT#S-300B) |
| Biotin-Lactosylceramide (Echelon Bioscience, CAT#S-600B) |
| Biotin-monolysocardiolipin (Echelon Bioscience, CAT#L-MB16) |
| Biotin-Phosphatidic Acid (Echelon Bioscience, CAT#L-41B16) |
| Biotin-Phosphatidylcholine (Echelon Bioscience, CAT#L-11B16) |
| Biotin-Phosphatidylethanol (12:0/18:1) (Echelon Bioscience, CAT#L-60B18) |
| Biotin-Phosphatidylethanol (6:0/16:0) (Echelon Bioscience, CAT#L-60B16) |
| Biotin-Phosphatidylethanolamine (Echelon Bioscience, CAT#L-21B6) |
| Biotin-Phosphatidylglycerol (Echelon Bioscience, CAT#L-51B16) |
| Biotin-Phosphatidylserine (Echelon Bioscience, CAT#L-31B16) |
| Biotinyl-alpha MSH [Nle4,DPhe7] (Echelon Bioscience, CAT#570-46) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-B345B) |
| Biotinylated Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-B345) |
| Biotinylated Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-B034) |
| Biotinylated Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-B045) |
| Biotinylated Select-HA 1000k (Echelon Bioscience, CAT#HYA-B1000-200) |
| Biotinylated Select-HA 250k (Echelon Bioscience, CAT#HYA-B250-200) |
| Biotinylated Select-HA 500k (Echelon Bioscience, CAT#HYA-B500-200) |
| Biotinylated Select-HA 50k (Echelon Bioscience, CAT#HYA-B50-200) |
| Biotinylated Versican G1 Domain (Echelon Bioscience, CAT#G-HA02) |
| Bisepoxy Juvenile Hormone III (Echelon Bioscience, CAT#S-0157) |
| BOC-Lys(Ac)-AMC (Histone Deacetylase (HDAC) Substrate) (Echelon Bioscience, CAT#888-20) |
| Boc-Val-Gly-Arg-bNA (Plasminogen Activator Substrate) (Echelon Bioscience, CAT#875-17) |
| BOC-Val-Pro-Arg-AFC (Thrombin substrate, fluorogenic) (Echelon Bioscience, CAT#885-11) |
| BODIPY FL Phosphatidylinositol (Echelon Bioscience, CAT#C-00F6) |
| BODIPY FL Phosphatidylinositol 4,5-bisphosphate (Echelon Bioscience, CAT#C-45F6) |
| BODIPY FL PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6) |
| BODIPY FL PI(3,4)P2 (Echelon Bioscience, CAT#C-34F6) |
| BODIPY FL PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6) |
| BODIPY FL PI(3)P (Echelon Bioscience, CAT#C-03F6) |
| BODIPY FL PI(4)P (Echelon Bioscience, CAT#C-04F6) |
| BODIPY FL PI(5)P (Echelon Bioscience, CAT#C-05F6) |
| Bodipy Labeled PIP Sample Pack (Echelon Bioscience, CAT#C-99F6) |
| BODIPY TMR Phosphatidylinositol (Echelon Bioscience, CAT#C-00M6) |
| BODIPY TMR PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6) |
| BODIPY TMR PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6) |
| BODIPY TMR PI(3,5)P2 (Echelon Bioscience, CAT#C-35M6) |
| BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6) |
| BODIPY TMR PI(4,5)P2 (Echelon Bioscience, CAT#C-45M6) |
| BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6) |
| BODIPY TMR PI(5)P (Echelon Bioscience, CAT#C-05M6) |
| BODIPY-FL PEth (Echelon Bioscience, CAT#L-60F18) |
| Bombesin (Echelon Bioscience, CAT#177-25) |
| Bovine Adrenal Medulla Docosapeptide / BAM 22P (Echelon Bioscience, CAT#313-45) |
| Bovine Thrombin (Echelon Bioscience, CAT#E-9000) |
| Bradykinin (1-7) (Echelon Bioscience, CAT#191-72) |
| Bradykinin (1-9) (Echelon Bioscience, CAT#191-25) |
| Bradykinin B2 Antagonist (HOE 140) (Echelon Bioscience, CAT#191-85) |
| Bradykinin Ile-Ser, (T-Kinin) (Echelon Bioscience, CAT#191-49) |
| Bradykinin Potentiating Factor (Angiotensin Converting Enzyme Inhibitor) (Echelon Bioscience, CAT#131-95) |
| Brain Derived Acidic Fibroblast Growth Factor (1-11), bovine (Echelon Bioscience, CAT#510-42) |
| Brain Natriuretic Peptide (BNP) (1-32), human / Brain ANP (1-32), human (Echelon Bioscience, CAT#152-52) |
| BrP-LPA (Echelon Bioscience, CAT#L-7416) |
| C-Peptide [Tyr0] / Proinsulin (32-63) Tyr0 (Echelon Bioscience, CAT#211-27) |
| C-Type Natriuretic Peptide (CNP) (1-22), human (Echelon Bioscience, CAT#151-60) |
| C6NIB (H2O2 vapor sensor) (Echelon Bioscience, CAT#D-0020) |
| Caerulein (ceruletide) (Echelon Bioscience, CAT#471-65) |
| Calcitonin Gene Related Peptide (CGRP), human (Echelon Bioscience, CAT#231-27) |
| Calcitonin Gene Related Peptide I (8-37), human / CGRP Receptor Antagonist (Echelon Bioscience, CAT#231-31) |
| Calcitonin Gene Related Peptide II (8-37), human / Beta CGRP (Echelon Bioscience, CAT#231-22) |
| Calcitonin Gene Related Peptide II (CGRP II, human), cyclic (Echelon Bioscience, CAT#231-29) |
| Calcitonin, human, cyclic (Echelon Bioscience, CAT#231-25) |
| Calcitonin, salmon (Echelon Bioscience, CAT#237-26) |
| Calcitonin, salmon [Des-Cys1] (Echelon Bioscience, CAT#237-34) |
| Calcitonin, salmon [Des-Tyr22] (Echelon Bioscience, CAT#237-32) |
| Calmodulin Binding Domain Ca2+/Calmodulin Dependent Protein (Echelon Bioscience, CAT#740-60) |
| Calmodulin Dependent Protein Kinase Substrate (Echelon Bioscience, CAT#890-81) |
| Calmodulin Kinase II Inhibitor (281-309) (Echelon Bioscience, CAT#893-40) |
| Calpastatin Peptide (Ac 184-210 ) (Echelon Bioscience, CAT#870-20) |
| cAMP Dependent Protein Kinase Inhibitor 5-24 amide (Echelon Bioscience, CAT#891-14) |
| cAMP Dependent Protein Kinase Inhibitor PKI-tide (Echelon Bioscience, CAT#892-20) |
| Cardioexcitatory Peptide, African giant snail (Echelon Bioscience, CAT#610-74) |
| Cardiolipin Beads (Echelon Bioscience, CAT#P-BCLP) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-56) |
| Casein Kinase Substrate (Echelon Bioscience, CAT#871-52) |
| Cathepsin D and E substrate, fluorogenic (Echelon Bioscience, CAT#866-41) |
| Cathepsin D Substrate (Echelon Bioscience, CAT#880-42) |
| Cathepsin L Inhibitor (Echelon Bioscience, CAT#866-23) |
| Cathepsin S Substrate, fluorogenic (Echelon Bioscience, CAT#866-80) |
| CDP-ME Kinase (IspE) (Echelon Bioscience, CAT#E-2000E) |
| CDP-ME Synthase (IspD) (Echelon Bioscience, CAT#E-2000D) |
| CDP-ME Synthase (IspD) Enzymatic Assay (Echelon Bioscience, CAT#K-2000D) |
| CDP-MEP Synthesis Kit (Echelon Bioscience, CAT#K-2000E) |
| Cecropin B (Echelon Bioscience, CAT#893-50) |
| Cecropin P1, porcine (Echelon Bioscience, CAT#893-60) |
| Cell Adhesion Inhibitor Peptide, cyclic (Echelon Bioscience, CAT#451-40) |
| Cell Permeable Caspase 1 Inhibitor (Echelon Bioscience, CAT#864-38) |
| Cell Permeable Caspase 3 Inhibitor (Echelon Bioscience, CAT#864-29) |
| Cell Permeable Caspase 6 Inhibitor (Echelon Bioscience, CAT#864-31) |
| Ceramide 1-Phosphate (C1P) Beads (Echelon Bioscience, CAT#P-BC1P) |
| Ceramide Beads (Echelon Bioscience, CAT#P-BCER) |
| Ceranib-2 (Ceramidase inhibitor) (Echelon Bioscience, CAT#B-0043) |
| cGMP Dep. Protein Kinase Substrate (BPDEide) (Echelon Bioscience, CAT#870-78) |
| Charybdotoxin, cyclic (Echelon Bioscience, CAT#429-60) |
| Chemotactic Peptide (Formyl-Met-Leu-Phe-OH) (Echelon Bioscience, CAT#850-15) |
| Chitin Polymer (Echelon Bioscience, CAT#H-10CH) |
| Cholecystokinin Octapeptide (26-33) / CCK 8 (Echelon Bioscience, CAT#471-47) |
| Cholecystokinin Octapeptide (26-33) Non-Sulfated / CCK-NSE O (Echelon Bioscience, CAT#471-48) |
| Cholesterol (Echelon Bioscience, CAT#L-6012) |
| Cholesterol Beads (Echelon Bioscience, CAT#P-BCHL) |
| Chromogranin A (324-337) WE 14, human (Echelon Bioscience, CAT#474-70) |
| Cionin (Echelon Bioscience, CAT#477-49) |
| Class I PI3-Kinase Reaction Buffer (Echelon Bioscience, CAT#K-KBZ) |
| Class III PI3K ELISA Kit (Echelon Bioscience, CAT#K-3000) |
| cMEPP Synthase (IspF) (Echelon Bioscience, CAT#E-2000F) |
| CML ELISA Kit II (Echelon Bioscience, CAT#K-3900S) |
| Coagulation Factor XIIIA (72-97) (Echelon Bioscience, CAT#459-15) |
| Colipase Activation Peptide (Echelon Bioscience, CAT#873-30) |
| Collagen Hybridizing Peptide – Biotin conjugate (CHP) (Echelon Bioscience, CAT#BIO) |
| Collagen Hybridizing Peptide – Cy3 Conjugate (Echelon Bioscience, CAT#RED) |
| Collagen Hybridizing Peptide – Fluorescein Conjugate (Echelon Bioscience, CAT#FLU) |
| Control Beads (Echelon Bioscience, CAT#P-B000) |
| Control PolyPIPosomes (Echelon Bioscience, CAT#Y-0000) |
| Corazonin, Periplaneta Americana (Echelon Bioscience, CAT#619-47) |
| Corticotropin Releasing Factor (CRF) human, rat (Echelon Bioscience, CAT#351-25) |
| Corticotropin Releasing Factor [Tyr0], ovine / CRF [Tyr0], o (Echelon Bioscience, CAT#352-37) |
| Corticotropin Releasing Factor, bovine, CRF, bovine (Echelon Bioscience, CAT#353-26) |
| Corticotropin Releasing Factor, ovine / CRF, ovine (Echelon Bioscience, CAT#352-26) |
| Cova PIP Screening Plate (Echelon Bioscience, CAT#H-6200) |
| CREBtide (Echelon Bioscience, CAT#890-15) |
| Cu(II) Protoporphyrin IX, 14494-37-2 (Echelon Bioscience, CAT#F-H070) |
| Custom Lipid Array Strip (Echelon Bioscience, CAT#P-6111) |
| CYM50308 (S1P4 Receptor Agonist) (Echelon Bioscience, CAT#B-0060) |
| D-erythro-Sphingosine (Echelon Bioscience, CAT#S-1000) |
| D-Ile-Pro-Arg-AMC (Echelon Bioscience, CAT#855-18) |
| D-Ile-Pro-Arg-pNA (Echelon Bioscience, CAT#855-19) |
| D-Phe-Pro-Lys-pNA (Thrombin Substrate colorimetric) (Echelon Bioscience, CAT#885-49) |
| D-sn-1-O-oleoyl-2-O-methylglyceryl-3-phosphothionate (2R-OMPT) (Echelon Bioscience, CAT#L-9318) |
| D-Val-Gly-Arg-pNA (Echelon Bioscience, CAT#855-31) |
| D-Val-Leu-Arg-AFC (Kallikrein substrate, fluorogenic) (Echelon Bioscience, CAT#871-84) |
| D-Val-Leu-Arg-AMC (Kallikrein Substrate, fluorogenic) (Echelon Bioscience, CAT#871-81) |
| D-Val-Leu-Arg-pNA (Kallikrein Substrate, colorimetric) (Echelon Bioscience, CAT#871-82) |
| D-Val-Leu-Lys-AFC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-22) |
| D-Val-Leu-Lys-AMC (Plasmin Substrate, fluorogenic) (Echelon Bioscience, CAT#872-18) |
| D-Val-Leu-Lys-pNA (Plasmin substrate colorimetric) (Echelon Bioscience, CAT#872-21) |
| D-Val-Lys-Lys-Arg-AMC (Echelon Bioscience, CAT#855-44) |
| d5-PAPEth (Echelon Bioscience, CAT#L-6055) |
| d5-PLPEth (Echelon Bioscience, CAT#L-6052) |
| d5-POPEth (Echelon Bioscience, CAT#L-6051) |
| d5-SLPEth (Echelon Bioscience, CAT#L-6054) |
| d5-SOPEth (Echelon Bioscience, CAT#L-6053) |
| DAPC (20:0 PC) (Echelon Bioscience, CAT#L-1120) |
| DBPC (PLA2 Substrate) (Echelon Bioscience, CAT#L-3000) |
| Decorsin, Leech (Macrobdella decora) (Echelon Bioscience, CAT#459-10) |
| Decyl Rhamnoside (Echelon Bioscience, CAT#RL10-1) |
| Dermaseptin (Echelon Bioscience, CAT#889-15) |
| DES1 Inhibitor (Echelon Bioscience, CAT#B-0027) |
| Desmopressin, [D-Gln4] Disulfide Bridge 1-6, Acetate (Echelon Bioscience, CAT#671-18) |
| Desmopressin, [L-Arg8], Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-20) |
| Desmopressin, Disulfide Bridge 1-6 (Echelon Bioscience, CAT#671-19) |
| DHPS (6:0/6:0 PS) (Echelon Bioscience, CAT#L-3106) |
| Dibromobimane (Echelon Bioscience, CAT#F-0040) |
| Dilauroyl-sn-glycerol (Echelon Bioscience, CAT#L-0012) |
| Dimethylallyl Diphosphate (DMAPP) (Echelon Bioscience, CAT#I-0051) |
| Dimethylallyl S-Thiolodiphosphate (DMASPP) (Echelon Bioscience, CAT#I-S051) |
| Dimyristoyl-sn-glycerol (Echelon Bioscience, CAT#L-0014) |
| Dipalmitoyl-sn-glycerol (Echelon Bioscience, CAT#L-0016) |
| DLPA (12:0/12:0 PA) (Echelon Bioscience, CAT#L-4112) |
| DLPC (12:0/12:0 PC) (Echelon Bioscience, CAT#L-1112) |
| DLPE (12:0/12:0 PE) (Echelon Bioscience, CAT#L-2112) |
| DLPG (12:0/12:0 PG) (Echelon Bioscience, CAT#L-5112) |
| DMOG (dimethyloxalylglycine) (Echelon Bioscience, CAT#F-0010) |
| DMPA (14:0/14:0 PA) (Echelon Bioscience, CAT#L-4114) |
| DMPC (14:0/14:0 PC) (Echelon Bioscience, CAT#L-1114) |
| DMPE (14:0/14:0 PE) (Echelon Bioscience, CAT#L-2114) |
| DMPG (14:0/14:0 PG) (Echelon Bioscience, CAT#L-5114) |
| Dnp-Pro-Leu-Ala-Tyr-Trp-Ala-Arg-OH (MMP 8 Substrate) (Echelon Bioscience, CAT#868-44) |
| Dnp-Pro-Leu-Gly-Met-Trp-Ser-Arg-OH (MMP-2 / MMP-9 Substrate) (Echelon Bioscience, CAT#865-10) |
| DOPC (18:1/18:1 PC) (Echelon Bioscience, CAT#L-1182) |
| DOPE (18:1/18:1 PE) (Echelon Bioscience, CAT#L-2182) |
| DOPEth (18:1/18:1 PEth) (Echelon Bioscience, CAT#L-6018) |
| DPePC (Echelon Bioscience, CAT#L-1162) |
| DPPA (16:0/16:0 PA) (Echelon Bioscience, CAT#L-4116) |
| DPPC (16:0/16:0 PC) (Echelon Bioscience, CAT#L-1116) |
| DPPE (16:0/16:0 PE) (Echelon Bioscience, CAT#L-2116) |
| DPPG (16:0/16:0 PG) (Echelon Bioscience, CAT#L-5116) |
| DPPS (16:0/16:0 PS) (Echelon Bioscience, CAT#L-3116) |
| DSPA (18:0/18:0 PA) (Echelon Bioscience, CAT#L-4118) |
| DSPC (18:0 PC) (Echelon Bioscience, CAT#L-1118) |
| DSPE (18:0/18:0 PE) (Echelon Bioscience, CAT#L-2118) |
| DSPG (18:0/18:0 PG) (Echelon Bioscience, CAT#L-5118) |
| DXP Synthase (DXS) (Echelon Bioscience, CAT#E-20DXS) |
| Dynorphin A (1-8), porcine (Echelon Bioscience, CAT#274-82) |
| Dynorphin A, porcine [Prodynorphin (209-225)] (Echelon Bioscience, CAT#274-27) |
| Dynorphin B, porcine / Rimorphin / Prodynorphin (228-240) (Echelon Bioscience, CAT#274-50) |
| ECE-1 Substrate (Echelon Bioscience, CAT#331-72) |
| Endomorphin I (Echelon Bioscience, CAT#311-88) |
| Endomorphin II (Echelon Bioscience, CAT#311-89) |
| Endothelin 2, human / ET 2 (Echelon Bioscience, CAT#331-20) |
| Endothelin 1, human (Echelon Bioscience, CAT#331-25) |
| Endothelin 3, cyclic (human, mouse, rabbit, rat) (Echelon Bioscience, CAT#335-10) |
| Endothelin Antagonist BQ 123, cyclic (Echelon Bioscience, CAT#331-10) |
| Endothelin Antagonist PD 142893 (Echelon Bioscience, CAT#331-17) |
| Endothelin Beta Receptor Agonist IRL 1620 (Echelon Bioscience, CAT#331-11) |
| Endothelin Beta Receptor Antagonist IRL 1038 (Echelon Bioscience, CAT#331-13) |
| Endothelin Receptor Antagonist BQ 3020 / Acetyl-(Ala11,15)-ET (Echelon Bioscience, CAT#331-14) |
| Endothelin Receptor Antagonist W 7338A (Echelon Bioscience, CAT#331-16) |
| Enkephalin Analog (Echelon Bioscience, CAT#311-55) |
| Enkephalinamide [D-Met2,Pro5] (Echelon Bioscience, CAT#310-47) |
| Epidermal Growth Factor (20-31) [Cys (Acm 20,31)] / EGF (Echelon Bioscience, CAT#510-50) |
| ET A Receptor Antagonist JKC 301 (Echelon Bioscience, CAT#331-51) |
| ET Antagonist PD 156252 (Echelon Bioscience, CAT#331-19) |
| ET Receptor Antagonist (PD 145065) (Echelon Bioscience, CAT#331-18) |
| Ether C12 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B120E) |
| Ether C18 Lysobisphosphatidic acid (Echelon Bioscience, CAT#L-B180E) |
| Exendin 3 (Echelon Bioscience, CAT#507-79) |
| Exendin 3 (9-39) Fragment (Echelon Bioscience, CAT#507-81) |
| Exendin 4 (Echelon Bioscience, CAT#507-77) |
| ExoClean – EV Purification Kit (Echelon Bioscience, CAT#K-4300a) |
| ExoTracker – Membrane (Echelon Bioscience, CAT#K-4300b) |
| ExoTracker – RNA (Echelon Bioscience, CAT#K-4300c) |
| ExoTracker – Total (Echelon Bioscience, CAT#K-4300d) |
| Extracellular Death Factor (Echelon Bioscience, CAT#950-10) |
| Farnesyl Diphosphate (FPP) (Echelon Bioscience, CAT#I-0150) |
| Farnesyl S-Thiolodiphosphate (FSPP) (Echelon Bioscience, CAT#I-S150) |
| Fibrinogen Binding Inhibitory Peptide (Echelon Bioscience, CAT#431-55) |
| Fibrinogen Fragment (Echelon Bioscience, CAT#450-16) |
| Fibrinopeptide A [Tyr0], human (Echelon Bioscience, CAT#431-31) |
| Fibrinopeptide B [Glu1], (human) (Echelon Bioscience, CAT#431-39) |
| Fibrinopeptide B, human (Echelon Bioscience, CAT#431-36) |
| Fibronectin Fragment (Echelon Bioscience, CAT#450-59) |
| Flow PIPs: Multiplex Lipid Beads (Echelon Bioscience, CAT#P-FB01) |
| Fluorescein conjugated Anti-PI(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-G345) |
| Fluorescein conjugated Anti-PI(4,5)P2 IgM (Echelon Bioscience, CAT#Z-G045) |
| Fluorescein Monolysocardiolipin (Echelon Bioscience, CAT#L-M16F) |
| Fluorescent Carrier Pack (Echelon Bioscience, CAT#P-9CFL) |
| FPA-124 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0101) |
| FR-1, cyclic (Echelon Bioscience, CAT#450-53) |
| FR900098 (Echelon Bioscience, CAT#B-4202) |
| FS-3 (LysoPLD / Autotaxin substrate) (Echelon Bioscience, CAT#L-2000) |
| FTY720 (Echelon Bioscience, CAT#B-0720) |
| Furin Inhibitor II (Echelon Bioscience, CAT#855-10) |
| G-Subtide (Echelon Bioscience, CAT#871-15) |
| Galanin, rat (Echelon Bioscience, CAT#475-25) |
| Galanin, human (Echelon Bioscience, CAT#471-22) |
| Galanin, porcine (Echelon Bioscience, CAT#471-25) |
| Galantide (Echelon Bioscience, CAT#471-02) |
| Gamma Secretase Inhibitor (Echelon Bioscience, CAT#649-27) |
| Ganirelix (Echelon Bioscience, CAT#557-31) |
| Gastric Inhibitory Peptide (GIP), human (Echelon Bioscience, CAT#471-75) |
| Gastrin (1-17) [Gly18], human (Echelon Bioscience, CAT#471-89) |
| Gastrin (2-17) [Leu15,Gly18] / MSI 1771 (Echelon Bioscience, CAT#471-83) |
| Gastrin I (1-14) (Echelon Bioscience, CAT#471-79) |
| Gastrin I, human (Echelon Bioscience, CAT#471-73) |
| Gastrin II SE, human (Echelon Bioscience, CAT#471-74) |
| Gastrin Releasing Peptide, human / GRP, h (Echelon Bioscience, CAT#471-85) |
| Geranyl Diphosphate (GPP) (Echelon Bioscience, CAT#I-0100) |
| Geranyl S-Thiolodiphosphate (GSPP) (Echelon Bioscience, CAT#I-S100) |
| Geranylgeranyl Diphosphate (GGPP) (Echelon Bioscience, CAT#I-0200) |
| Geranylgeranyl S-thiodiphosphate (GGSPP) (Echelon Bioscience, CAT#I-S200) |
| Ghrelin (rat) (Echelon Bioscience, CAT#551-15) |
| Ghrelin, human (Echelon Bioscience, CAT#551-10) |
| GloPIPs Biotin-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39B6A) |
| GloPIPs Biotin-PI(3,4)P2 (Echelon Bioscience, CAT#C-34B6A) |
| GloPIPs Biotin-PI(3,5)P2 (Echelon Bioscience, CAT#C-35B6A) |
| GloPIPs Biotin-PI(3)P (Echelon Bioscience, CAT#C-03B6A) |
| GloPIPs Biotin-PI(4,5)P2 (Echelon Bioscience, CAT#C-45B6a) |
| GloPIPs Biotin-PI(4)P (Echelon Bioscience, CAT#C-04B6A) |
| GloPIPs Biotin-PI(5)P (Echelon Bioscience, CAT#C-05B6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39F6A) |
| GloPIPs BODIPY FL-PI(3,4,5)P3, C16 (Echelon Bioscience, CAT#C-39F16A) |
| GloPIPs BODIPY FL-PI(3,5)P2 (Echelon Bioscience, CAT#C-35F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2 (Echelon Bioscience, CAT#C-45F6A) |
| GloPIPs BODIPY FL-PI(4,5)P2, C16 (Echelon Bioscience, CAT#C-45F16A) |
| GloPIPs BODIPY FL-PI(4)P (Echelon Bioscience, CAT#C-04F6A) |
| GloPIPs BODIPY TMR PI(3)P (Echelon Bioscience, CAT#C-03M6A) |
| GloPIPs BODIPY TMR PI(4)P (Echelon Bioscience, CAT#C-04M6A) |
| GloPIPs BODIPY TMR-PI(3,4,5)P3 (Echelon Bioscience, CAT#C-39M6A) |
| GloPIPs BODIPY TMR-PI(3,4)P2 (Echelon Bioscience, CAT#C-34M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2 (Echelon Bioscience, CAT#C-45M6A) |
| GloPIPs BODIPY TMR-PtdIns(4,5)P2, C16 (Echelon Bioscience, CAT#C-45M16A) |
| GLP 2 [Gly2], human (Echelon Bioscience, CAT#471-21) |
| GLP 2 [Tyr34] (1-34), human (Echelon Bioscience, CAT#471-19) |
| GLP-1 (9-36) , Glucagon-like Peptide 1 (Echelon Bioscience, CAT#471-42) |
| Glp-Pro-Val-pNA (Human Granulocyte Elastase Substrate, colorimetric) (Echelon Bioscience, CAT#871-19) |
| Glu-His-Tyr-Gln-AMC (Echelon Bioscience, CAT#877-01) |
| Glucagon-like Peptide-1, GLP-1 (7-36) / Preproglucagon (78-107) amide (Echelon Bioscience, CAT#471-28) |
| Glucagon-like Peptide-1, GLP-1 (7-37) human (Echelon Bioscience, CAT#471-39) |
| Glucagon-like Peptide-1, GLP-1 (Preproglucagon 72-107) amide (Echelon Bioscience, CAT#471-27) |
| Glucagon-like Peptide-1, human (Echelon Bioscience, CAT#471-26) |
| Glucagon-like Peptide-2, GLP-2 (1-33), rat / Preproglucagon (126-158) (Echelon Bioscience, CAT#471-23) |
| Glucagon-like Peptide-2, GLP-2, human / Preproglucagon (126-158), human (Echelon Bioscience, CAT#471-18) |
| Glucagon, human (Echelon Bioscience, CAT#471-30) |
| Gly-Arg-Ala-Asp-Ser-Pro (GRADSP) (Echelon Bioscience, CAT#450-36) |
| Gly-Arg-Gly-Asp-Ser (GRGDS) (Echelon Bioscience, CAT#450-38) |
| Gly-Arg-Gly-Asp-Ser-Pro (GRGDSP) (Echelon Bioscience, CAT#450-39) |
| Gly-Pro-Arg-Pro-NH2 (Echelon Bioscience, CAT#450-17) |
| Glycerophosphoinositol 5-phosphate (Gro PI(5)P) (Echelon Bioscience, CAT#P-5000) |
| GMAP (1-41), amide / Galanin Message Associated Peptide (1-41), amide (Echelon Bioscience, CAT#421-35) |
| Goat anti-human Autotaxin antibody (Echelon Bioscience, CAT#Z-P400) |
| Granuliberin R (Echelon Bioscience, CAT#880-87) |
| Granzyme A Substrate, fluorogenic (Echelon Bioscience, CAT#874-13) |
| GRF (1-44)NH2, bovine (Echelon Bioscience, CAT#535-15) |
| GRF, mouse (Echelon Bioscience, CAT#536-10) |
| GRI977143 (LPA2 Agonist) (Echelon Bioscience, CAT#B-0070) |
| GroPI (Echelon Bioscience, CAT#P-0000) |
| GroPI(3,4,5)P3 (Echelon Bioscience, CAT#P-3900) |
| GroPI(4,5)P2 (Echelon Bioscience, CAT#P-4500) |
| GroPI(4)P (Echelon Bioscience, CAT#P-4000) |
| Growth Hormone Releasing Factor [D-Ala2] (1-29) amide, human (Echelon Bioscience, CAT#531-76) |
| Growth Hormone Releasing Factor [His1,Nle27] (1-32) amide, human (Echelon Bioscience, CAT#531-74) |
| Growth Hormone Releasing Factor (1-29) amide, human / GRF (1-29), amide, human (Echelon Bioscience, CAT#531-75) |
| Growth Hormone Releasing Factor (1-40) amide, human; GRF (1-40) amide, human (Echelon Bioscience, CAT#531-67) |
| Growth Hormone Releasing Factor (1-40), human; GRF (1-40), human (Echelon Bioscience, CAT#531-68) |
| Growth Hormone Releasing Factor (1-44), porcine / GRF (1-44), porcine (Echelon Bioscience, CAT#534-29) |
| Growth Hormone Releasing Factor / GRF [Ac-Tyr1,D-Arg2] (1-29) amide (Echelon Bioscience, CAT#531-84) |
| Growth Hormone Releasing Factor, GRF (1-44) amide, human (Echelon Bioscience, CAT#531-66) |
| Growth Hormone Releasing Peptide 6 (GHRP-6) / GHRP [His1, Lys6] (Echelon Bioscience, CAT#531-18) |
| HA130 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0701) |
| HA30-BODIPY-FL (Echelon Bioscience, CAT#H-025F) |
| HA30-TexasRed (Echelon Bioscience, CAT#H-025R) |
| HA300-BODIPY-FL (Echelon Bioscience, CAT#H-250F) |
| HA300-TexasRed (Echelon Bioscience, CAT#H-250R) |
| HA850-BODIPY-FL (Echelon Bioscience, CAT#H-700F) |
| HA850-TexasRed (Echelon Bioscience, CAT#H-700R) |
| Helodermin [Gln8,9] (Echelon Bioscience, CAT#740-27) |
| Hemagglutination Inhibiting Peptide, human;from parotid secr (Echelon Bioscience, CAT#790-10) |
| Heme Oxygenase Inhibitor Toolbox (Echelon Bioscience, CAT#F-HOIT) |
| Hemin (Echelon Bioscience, CAT#F-H010) |
| Heparin ELISA (Echelon Bioscience, CAT#K-5300) |
| Hepatitis C Virus NS3 Protease Substrate, fluorogenic (Echelon Bioscience, CAT#732-35) |
| Herpes Virus Inhibitor 1 (Echelon Bioscience, CAT#732-36) |
| Herpes Virus Inhibitor 2 (Echelon Bioscience, CAT#872-39) |
| Hexadecyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0320) |
| High Mobility Group Box 1 (HMGB1) (Echelon Bioscience, CAT#G-HMGB1) |
| High Throughput Autotaxin Inhibitor Screening Kit (Echelon Bioscience, CAT#K-4200HTS) |
| Hirudin (54-65), Sulfated (Echelon Bioscience, CAT#873-20) |
| Hirudin Acetyl (54-65) Sulfated (Echelon Bioscience, CAT#873-15) |
| Histidine Tagged Versican G1 Domain (Echelon Bioscience, CAT#G-HA03) |
| Histone H2B (29-35) (Echelon Bioscience, CAT#870-75) |
| HIV Envelope Peptide GP 120, (307-330) (Echelon Bioscience, CAT#870-26) |
| HIV Substrate IV (Echelon Bioscience, CAT#870-15) |
| HIV-1 Protease Substrate (Echelon Bioscience, CAT#870-10) |
| HIV-TAT 48-57 JNK Inhibitor I (Echelon Bioscience, CAT#732-10) |
| HS014 / MSH Antagonist cyclic / File # 0045A (Echelon Bioscience, CAT#571-72) |
| Human Lysosomal Phospholipase A2 (hLPLA2), active (Echelon Bioscience, CAT#E-7000) |
| Humanin, human (Echelon Bioscience, CAT#640-52) |
| Hy-Pip Cova PIP Specificity Plate (Echelon Bioscience, CAT#H-6300) |
| Hyaluronan Enzyme-Linked Immunosorbent Assay (HA ELISA) (Echelon Bioscience, CAT#K-1200) |
| Hyaluronic Acid (HA) Screening Service (Echelon Bioscience, CAT#T-1200) |
| Hyaluronic Acid Sandwich ELISA (Echelon Bioscience, CAT#K-4800) |
| Hyaluronidase Activity ELISA (Echelon Bioscience, CAT#K-6000) |
| Hypertrehalosaemic Neuropeptide, german cockroach (Nauphoeta (Echelon Bioscience, CAT#619-58) |
| IC87114 (PI3-K delta inhibitor) (Echelon Bioscience, CAT#B-0305) |
| IGRP Catalytic Subunit (206-214) (Echelon Bioscience, CAT#471-58) |
| Innate Defense Regulator 1018 (IDR-1018) (Echelon Bioscience, CAT#745-20) |
| Inositol 1,2,6-trisphosphate (Ins(1,2,6)P3) (Echelon Bioscience, CAT#Q-0126) |
| Inositol 1,3-bisphosphate (Ins(1,3)P2) (Echelon Bioscience, CAT#Q-0013) |
| Inositol 1,3,4-trisphosphate (Ins(1,3,4)P3) (Echelon Bioscience, CAT#Q-0134) |
| Inositol 1,3,5-trisphosphate (Ins(1,3,5)P3) (Echelon Bioscience, CAT#Q-0135) |
| Inositol 1,4-bisphosphate (Ins(1,4)P2) (Echelon Bioscience, CAT#Q-0014) |
| Inositol 1,4,5-trisphosphate (Ins(1,4,5)P3) (Echelon Bioscience, CAT#Q-0145) |
| Inositol 1,5-bisphosphate (Ins(1,5)P2) (Echelon Bioscience, CAT#Q-0015) |
| INPP4 Activity Kit (Echelon Bioscience, CAT#K-5200) |
| INPP4A, active (Echelon Bioscience, CAT#E-8000) |
| Ins(1,3,4,5)P4 (Echelon Bioscience, CAT#Q-1345) |
| Ins(1,3,4,5)P4 Beads (Echelon Bioscience, CAT#Q-B1345) |
| Ins(1,3,4,5)P4 Biotin (Echelon Bioscience, CAT#Q-139B) |
| Ins(1,3,4,6)P4 (Echelon Bioscience, CAT#Q-1346) |
| Ins(1,4,5)P3 Beads (Echelon Bioscience, CAT#Q-B0145) |
| Ins(1,4,5)P3 Biotin (Echelon Bioscience, CAT#Q-145B) |
| IP3 Receptor Inhibitor 911 [Diphenyl (2,6-diaminohexanoate-O,N)-borane] (Echelon Bioscience, CAT#B-0370) |
| Isopentenyl Diphosphate (IPP) (Echelon Bioscience, CAT#I-0050) |
| Isopentenyl S-Thiolodiphosphate (ISPP) (Echelon Bioscience, CAT#I-S050) |
| IspF Inhibitor 1 (Echelon Bioscience, CAT#B-4102) |
| Juvenile Hormone III (racemic) (Echelon Bioscience, CAT#S-0155) |
| K118 (SHIP1 Inhibitor) (Echelon Bioscience, CAT#B-0344) |
| K149 (SHIP2 Inhibitor) (Echelon Bioscience, CAT#B-0345) |
| Kemptide (Phosphate Acceptor Peptide) (Echelon Bioscience, CAT#870-65) |
| Ki16425 (LPA Receptor Antagonist) (Echelon Bioscience, CAT#B-0730) |
| KISS (107-121) (Echelon Bioscience, CAT#548-19) |
| KISS (112-121) (Echelon Bioscience, CAT#548-17) |
| KISS-1 (125-144) (Echelon Bioscience, CAT#548-21) |
| KISS-1 (58-65) (Echelon Bioscience, CAT#548-11) |
| KISS-1 (68-80) (Echelon Bioscience, CAT#548-13) |
| KISS-1 (68-91) (Echelon Bioscience, CAT#548-14) |
| KISS-1 (94-121) (Echelon Bioscience, CAT#548-12) |
| KP372-1 (Akt Inhibitor) (Echelon Bioscience, CAT#B-0102) |
| L-Ascorbyl-6-stearate (Echelon Bioscience, CAT#R-1218) |
| Lactosylceramide (LacCer) Beads (Echelon Bioscience, CAT#P-B0LC) |
| Laminin (929-933) (Echelon Bioscience, CAT#736-21) |
| Laminin A (2091-2108) (Echelon Bioscience, CAT#736-10) |
| LBPA Beads (Echelon Bioscience, CAT#P-BLBPA) |
| Leu-Enkephalin (Echelon Bioscience, CAT#310-75) |
| Leu-Enkephalin [D-Ala2] (Echelon Bioscience, CAT#310-84) |
| Leucokinin I (Echelon Bioscience, CAT#341-29) |
| Leumorphin (human) (Preproenkephalin B 226-254) (Echelon Bioscience, CAT#271-35) |
| LH-RH [D-Ala6] (Echelon Bioscience, CAT#550-44) |
| LH-RH [D-Lys6] (Echelon Bioscience, CAT#550-46) |
| LH-RH [D-Lys6] Free Acid (Echelon Bioscience, CAT#551-46) |
| LH-RH [D-Phe2,D-Ala6] (Echelon Bioscience, CAT#550-45) |
| LH-RH [Hyp9] (Echelon Bioscience, CAT#557-45) |
| LH-RH Free Acid (Echelon Bioscience, CAT#551-27) |
| LH-RH II alligator, chicken (Echelon Bioscience, CAT#558-39) |
| Linolenoyl LPA, 18:3 LPA (Echelon Bioscience, CAT#L-0183) |
| Linoleoyl LPA-d5, 18:2 LPA-d5 (Echelon Bioscience, CAT#L-0182d) |
| Linoleoyl LPA, 18:2 LPA (Echelon Bioscience, CAT#L-0182) |
| Locustapyrokinin [Glu6], Locusta Migratoria (Echelon Bioscience, CAT#361-26) |
| Locustapyrokinin, L. Migratoria (Echelon Bioscience, CAT#361-25) |
| LPA Beads (Echelon Bioscience, CAT#L-6101) |
| LPA Biotin (Echelon Bioscience, CAT#L-012B) |
| LPA ELISA Assay Service (Echelon Bioscience, CAT#T-2800S) |
| LPLA2 Activity Assay (Echelon Bioscience, CAT#K-7000A) |
| LPLA2 Inhibitor Screen (Echelon Bioscience, CAT#K-7000I) |
| LPS (16:0) (Echelon Bioscience, CAT#L-3216) |
| LY294002 (PI3-K Inhibitor) (Echelon Bioscience, CAT#B-0294) |
| Lysophosphatidic Acid Antibody (504B3) (Echelon Bioscience, CAT#Z-P200) |
| Lysophosphatidic Acid ELISA Kit (Echelon Bioscience, CAT#K-2800S) |
| LysoPI, 16:0 LPI (Echelon Bioscience, CAT#P-0160) |
| Malachite Green Assay Kit (Echelon Bioscience, CAT#K-1500) |
| Malachite Green Solution (Echelon Bioscience, CAT#K-1501) |
| Mast Cell Degranulating Peptide HR-1 (Echelon Bioscience, CAT#429-35) |
| Mast Cell Degranulating Peptide HR-2 (Echelon Bioscience, CAT#429-37) |
| Mastoparan, hornet Vespa basalis (Echelon Bioscience, CAT#887-20) |
| Mca-Tyr-Val-Ala-Asp-Ala-Pro-Lys(DNP)-OH (Caspase 1 Substrate) (Echelon Bioscience, CAT#865-21) |
| Mca-Val-Asp-Val-Ala-Asp-Gly-Trp-Lys(DNP)-NH2 (Caspase 2 (ICH-1) Substrate ) (Echelon Bioscience, CAT#866-10) |
| Melanotan II, cyclic α-MSH (Echelon Bioscience, CAT#571-56) |
| Melittin (Echelon Bioscience, CAT#920-32) |
| Membrane Lipid Arrays (Echelon Bioscience, CAT#P-6003) |
| Membrane Lipid Strips (Echelon Bioscience, CAT#P-6002) |
| MeOSuc-Ala-Ala-Pro-Val-4MbNA (Pancreatic Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-19) |
| MeOSuc-Ala-Ala-Pro-Val-AFC Pancreatic Leukocyte Elastase Substrate, fluorogenic) (Echelon Bioscience, CAT#881-17) |
| MEP Synthase (DXR) Enzyme Inhibitor Screen (Echelon Bioscience, CAT#K-2000C) |
| MEP Synthase (DXR), active (Echelon Bioscience, CAT#E-2000C) |
| Mesobiliverdin (microbial sourced) (Echelon Bioscience, CAT#F-H160) |
| Met Enkephalin [Lys 6] (Echelon Bioscience, CAT#310-59) |
| Metastin, KISS -1 (68-121) (Echelon Bioscience, CAT#548-25) |
| Methoxysuccinyl-Ala-Ala-Arg-pNA (Echelon Bioscience, CAT#876-07) |
| Methoxysuccinyl-Pro-Ser-Pro-Phe-AMC (Echelon Bioscience, CAT#877-02) |
| Methyl glucoside sesquistearate (Echelon Bioscience, CAT#R-1018) |
| MG-115 (Proteasome Inhibitor) (Echelon Bioscience, CAT#882-10) |
| MG-132 Proteasome Inhibitor (Echelon Bioscience, CAT#882-11) |
| Miltefosine (Echelon Bioscience, CAT#L-1216) |
| Mini Gastrin I, human (Echelon Bioscience, CAT#471-11) |
| MMP 13 Substrate, fluorogenic (Echelon Bioscience, CAT#868-30) |
| MMP 14 substrate Stomelysine-3, fluorogenic (Echelon Bioscience, CAT#868-42) |
| MMP 2 Substrate, fluorogenic (Echelon Bioscience, CAT#868-20) |
| MMP Inhibitor I (Echelon Bioscience, CAT#868-75) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-22) |
| MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-41) |
| MMP-3 Inhibitor 1 (Echelon Bioscience, CAT#868-60) |
| MMP-3 Substrate, fluorogenic (Echelon Bioscience, CAT#868-62) |
| MMV008138(1R,3S) (IspD Inhibitor) (Echelon Bioscience, CAT#B-4103) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, human (Echelon Bioscience, CAT#651-10) |
| MOG Protein (35-55), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, rat (Echelon Bioscience, CAT#645-10) |
| MOG Protein (68-84), Myelin Oligodendrocyte Glycoprotein Peptide Fragment, guinea pig (Echelon Bioscience, CAT#920-63) |
| Monobromobimane (Echelon Bioscience, CAT#F-0030) |
| Monocaprin (Echelon Bioscience, CAT#L-9010) |
| Monolaurin (Echelon Bioscience, CAT#L-9012) |
| Monomyristin (Echelon Bioscience, CAT#L-9014) |
| MOPC (17:0/18:1 PC) (Echelon Bioscience, CAT#L-1117) |
| MOPEth (17:0/18:1 PEth) (Echelon Bioscience, CAT#L-6017) |
| Morphine Modulating Neuropeptide (Echelon Bioscience, CAT#340-79) |
| Motilin, dog (Echelon Bioscience, CAT#496-25) |
| Motilin, human (Echelon Bioscience, CAT#491-15) |
| ms-PtdIns(4,5)P2 diC16 (Echelon Bioscience, CAT#P-F4516) |
| ms-PtdIns(4,5)P2 diC8 (Echelon Bioscience, CAT#P-F4508) |
| MultiPIP Grip (Echelon Bioscience, CAT#G-9901) |
| Myelin Proteolipid Protein (139-151) [Ser 140] (depalmitoylated), h, b, d, m, r (Echelon Bioscience, CAT#720-10) |
| Myosin Light Chain Kinase (11-19) amide (Echelon Bioscience, CAT#892-96) |
| Myosin Light Chain Kinase Substrate (Smooth muscle) (Echelon Bioscience, CAT#930-30) |
| MZ-4-169 (Echelon Bioscience, CAT#531-92) |
| MZ-4-181 (Echelon Bioscience, CAT#531-93) |
| MZ-4-71 (Echelon Bioscience, CAT#531-91) |
| N-Acetyl Beta Endorphin, human (Echelon Bioscience, CAT#291-29) |
| N-arachidonoyl-DPPE (NAPE 20:4) (Echelon Bioscience, CAT#L-2404) |
| N-Biotin Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500B) |
| N-Linoleoyl-DPPE (Echelon Bioscience, CAT#L-2420) |
| N-NBD Ceramide 1-phosphate (Echelon Bioscience, CAT#S-500N6) |
| N-Oleoyl-DPPE (Echelon Bioscience, CAT#L-2419) |
| N-palmitoyl-DPPE (NAPE 16:0) (Echelon Bioscience, CAT#L-2416) |
| N-Stearoyl Ceramide 1-phosphate (Echelon Bioscience, CAT#S-5018) |
| N-Stearoyl-DPPE (Echelon Bioscience, CAT#L-2418) |
| nanoHA-5 (Echelon Bioscience, CAT#HYA-NANO5-1) |
| NBD-Phosphatidylethanol (Echelon Bioscience, CAT#L-60N16) |
| NeoBeads – PIP Purification System (Echelon Bioscience, CAT#P-B999) |
| Neryl Diphosphate (NPP) (Echelon Bioscience, CAT#I-0120) |
| Neurokinin A [Tyr5,DTrp6,8,9Lys10] (4-10) (Echelon Bioscience, CAT#631-70) |
| Neurokinin A [Ala5, BetaAla8],(4-10) (Echelon Bioscience, CAT#631-65) |
| Neuromedin B (Echelon Bioscience, CAT#630-62) |
| Neuromedin N (Echelon Bioscience, CAT#634-46) |
| Neuromedin U-8 (Echelon Bioscience, CAT#630-65) |
| Neuropeptide Y (3-36), human, rat / NPY (3-36) (Echelon Bioscience, CAT#614-41) |
| Neuropeptide Y (3-36), porcine / NPY (3-36) (Echelon Bioscience, CAT#614-39) |
| Neuropeptide Y (human, rat) (Echelon Bioscience, CAT#611-26) |
| Neuropeptide Y, porcine / NPY, porcine (Echelon Bioscience, CAT#614-30) |
| Neurotensin [D-Trp11] (Echelon Bioscience, CAT#631-38) |
| Neurotensin, human (Echelon Bioscience, CAT#631-27) |
| Neutral Sphingomyelinase Activity Assay Kit (Echelon Bioscience, CAT#K-1800) |
| Neutral Sphingomyelinase Assay Service (Echelon Bioscience, CAT#T-1800) |
| NFF 2 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-25) |
| NFF 3 MMP Substrate, fluorogenic (Echelon Bioscience, CAT#868-10) |
| Nociceptin/Orphanin FQ (Echelon Bioscience, CAT#310-78) |
| NOG (N-oxalylglycine) (Echelon Bioscience, CAT#F-0020) |
| Non-A-Beta Component Amyloid (Echelon Bioscience, CAT#641-80) |
| Nonfluorescent Carrier Pack (Echelon Bioscience, CAT#P-9C00) |
| NVP-231 (Ceramide Kinase Inhibitor) (Echelon Bioscience, CAT#B-0040) |
| Obestatin (11-23), mouse (Echelon Bioscience, CAT#475-96) |
| Obestatin, human (Echelon Bioscience, CAT#471-97) |
| Obestatin, mouse (Echelon Bioscience, CAT#475-97) |
| Octreotide (Echelon Bioscience, CAT#690-44) |
| Oleoyl 3-carbacyclic Phosphatidic Acid (Echelon Bioscience, CAT#L-7218) |
| Oleoyl LPA, 18:1 LPA (Echelon Bioscience, CAT#L-0181) |
| Oral Formulation Vehicle (Echelon Bioscience, CAT#B-0706) |
| Orexin A (human, rat, mouse) (Echelon Bioscience, CAT#471-99) |
| Orexin A, Xenopus SS (4-10/5-12) (Echelon Bioscience, CAT#479-99) |
| Orexin B, human (Echelon Bioscience, CAT#471-98) |
| Oxyntomodulin (Glucagon 1-37) (Echelon Bioscience, CAT#471-33) |
| Oxytocin (Echelon Bioscience, CAT#670-67) |
| p-I-L-Phe4 human beta amyloid (1-40) (Echelon Bioscience, CAT#640-33) |
| P-lysoPC (16:0 LPC) (Echelon Bioscience, CAT#L-1516) |
| PACAP (1-27), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-37) |
| PACAP (1-38), ovine, human / Adenylate Cyclase Activating Po (Echelon Bioscience, CAT#350-35) |
| Palmitoyl-DHAP (ammonium salt) (Echelon Bioscience, CAT#L-0310) |
| Pancreastatin (1-52), human (Echelon Bioscience, CAT#481-20) |
| Pancreatic Elastase Substrate, colorimetric (Echelon Bioscience, CAT#883-18) |
| Pancreatic Leukocyte Elastase Substrate, colorimetric (Echelon Bioscience, CAT#881-15) |
| Pancreatic polypeptide bovine (Echelon Bioscience, CAT#474-21) |
| Pancreatic Polypeptide, avian (Echelon Bioscience, CAT#478-40) |
| PAPEth (16:0/20:4 PEth) (Echelon Bioscience, CAT#L-6024) |
| PAR (1-6) amide [Ala1], Mouse (Echelon Bioscience, CAT#875-28) |
| PAR-1 agonist (Echelon Bioscience, CAT#875-27) |
| PAR-2 (1-6)amide human (Echelon Bioscience, CAT#875-23) |
| Parathyroid Hormone (PTH) (1-34), human (Echelon Bioscience, CAT#231-40) |
| Parathyroid Hormone (PTH) (1-34), rat (Echelon Bioscience, CAT#235-36) |
| Parathyroid Hormone (PTH) (2-34), human (Echelon Bioscience, CAT#231-43) |
| Parathyroid Hormone (PTH) (3-34), human (Echelon Bioscience, CAT#231-46) |
| Parathyroid Hormone (PTH) (39-68), human (Echelon Bioscience, CAT#231-50) |
| Parathyroid Hormone (PTH) (39-84), human (Echelon Bioscience, CAT#231-55) |
| Parathyroid Hormone (PTH) (4-34), human (Echelon Bioscience, CAT#231-48) |
| Parathyroid Hormone (PTH) (5-34), human (Echelon Bioscience, CAT#231-51) |
| Parathyroid Hormone (PTH) (53-84), human (Echelon Bioscience, CAT#231-60) |
| Parathyroid Hormone (PTH) [Nle8,18,Tyr34] (3-34), amide, bovine (Echelon Bioscience, CAT#233-35) |
| Parathyroid Hormone [Nle8,18,Tyr34](1-34) amide, bovine (Echelon Bioscience, CAT#233-32) |
| PC Lipid Microparticles (Echelon Bioscience, CAT#P-B1PC) |
| PC/PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PCPS) |
| PDQ, Antimicrobial Peptide from Xenopus Laevis (Echelon Bioscience, CAT#745-10) |
| Peptide YY, PYY (3-36) , canine , mouse , porcine , rat (Echelon Bioscience, CAT#490-56) |
| Peptide YY, PYY (3-36), human (Echelon Bioscience, CAT#490-11) |
| PF-543 (Sphingosine Kinase I Inhibitor) (Echelon Bioscience, CAT#B-0026) |
| PF-8380 (Autotaxin Inhibitor) (Echelon Bioscience, CAT#B-0702) |
| Phe-Met-Arg-D-Phe-NH2 (Echelon Bioscience, CAT#610-49) |
| Phe-Met-Arg-Phe-NH2 (FMRF Peptide) (Echelon Bioscience, CAT#610-44) |
| Pheromonotropin, Pseudalatia (Echelon Bioscience, CAT#782-10) |
| PHI, rat (Echelon Bioscience, CAT#495-25) |
| Phosphatase Substrate (Echelon Bioscience, CAT#871-70) |
| Phosphatidic Acid (PA) Beads (Echelon Bioscience, CAT#P-B0PA) |
| Phosphatidylcholine (PC) Beads (Echelon Bioscience, CAT#P-B0PC) |
| Phosphatidylethanol (PEth) Beads (Echelon Bioscience, CAT#P-BPETH) |
| Phosphatidylethanol (PEth) ELISA (Echelon Bioscience, CAT#K-5000) |
| Phosphatidylethanolamine (PE) Beads (Echelon Bioscience, CAT#P-B0PE) |
| Phosphatidylinositol 4,5-bisphosphate 18:0/20:4 (Echelon Bioscience, CAT#P-4524) |
| Phosphatidylinositol diC16 (PI diC16) (Echelon Bioscience, CAT#P-0016) |
| Phosphatidylinositol diC4 (PI diC4) (Echelon Bioscience, CAT#P-0004) |
| Phosphatidylinositol diC8 (ammonium salt) (Echelon Bioscience, CAT#P-0008A) |
| Phosphatidylinositol diC8 (PI diC8) (Echelon Bioscience, CAT#P-0008) |
| Phosphatidylserine (PS) Beads (Echelon Bioscience, CAT#P-B0PS) |
| Phospholipase A2 activating peptide (Echelon Bioscience, CAT#495-26) |
| PI PolyPIPosomes (Echelon Bioscience, CAT#Y-P000) |
| PI-103 (PI3-K alpha Inhibitor 1) (Echelon Bioscience, CAT#B-0303) |
| PI(3,4,5)P3 17:0/16:0 (Echelon Bioscience, CAT#P-3917) |
| PI(3,4,5)P3 18:0/20:4 (Echelon Bioscience, CAT#P-3924) |
| PI(3,4,5)P3 diC16 (Echelon Bioscience, CAT#P-3916) |
| PI(3,4,5)P3 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3916A) |
| PI(3,4,5)P3 diC4 (Echelon Bioscience, CAT#P-3904) |
| PI(3,4,5)P3 diC8 (Echelon Bioscience, CAT#P-3908) |
| PI(3,4,5)P3 Grip (Grp1-PH) (Echelon Bioscience, CAT#G-3901) |
| PI(3,4,5)P3 PIP Beads (Echelon Bioscience, CAT#P-B345A) |
| PI(3,4,5)P3 PolyPIPosomes (Echelon Bioscience, CAT#Y-P039) |
| PI(3,4)P2 diC16 (Echelon Bioscience, CAT#P-3416) |
| PI(3,4)P2 diC16 (ammonium salt) (Echelon Bioscience, CAT#P-3416A) |
| PI(3,4)P2 diC4 (Echelon Bioscience, CAT#P-3404) |
| PI(3,4)P2 diC8 (Echelon Bioscience, CAT#P-3408) |
| PI(3,4)P2 Mass ELISA (Echelon Bioscience, CAT#K-3800) |
| PI(3,4)P2 PIP Beads (Echelon Bioscience, CAT#P-B034A) |
| PI(3,4)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P034) |
| PI(3,5)P2 diC16 (Echelon Bioscience, CAT#P-3516) |
| PI(3,5)P2 diC4 (Echelon Bioscience, CAT#P-3504) |
| PI(3,5)P2 diC8 (Echelon Bioscience, CAT#P-3508) |
| PI(3,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B035A) |
| PI(3,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P035) |
| PI(3)P diC16 (Echelon Bioscience, CAT#P-3016) |
| PI(3)P diC4 (Echelon Bioscience, CAT#P-3004) |
| PI(3)P diC8 (Echelon Bioscience, CAT#P-3008) |
| PI(3)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-3008A) |
| PI(3)P Grip (p40 PX) (Echelon Bioscience, CAT#G-0302) |
| PI(3)P Mass ELISA (Echelon Bioscience, CAT#K-3300) |
| PI(3)P PIP Beads (Echelon Bioscience, CAT#P-B003A) |
| PI(3)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P003) |
| PI(4,5)P2 diC16 (Echelon Bioscience, CAT#P-4516) |
| PI(4,5)P2 diC4 (Echelon Bioscience, CAT#P-4504) |
| PI(4,5)P2 diC8 (Echelon Bioscience, CAT#P-4508) |
| PI(4,5)P2 Grip (PLC-d1-PH) (Echelon Bioscience, CAT#G-4501) |
| PI(4,5)P2 Mass ELISA Kit (Echelon Bioscience, CAT#K-4500) |
| PI(4,5)P2 PIP Beads (Echelon Bioscience, CAT#P-B045A) |
| PI(4,5)P2 PolyPIPosomes (Echelon Bioscience, CAT#Y-P045) |
| PI(4)P 5-Kinase (PIP5KI) Activity Assay (Echelon Bioscience, CAT#K-5700) |
| PI(4)P diC16 (Echelon Bioscience, CAT#P-4016) |
| PI(4)P diC4 (Echelon Bioscience, CAT#P-4004) |
| PI(4)P diC8 (Echelon Bioscience, CAT#P-4008) |
| PI(4)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-4008A) |
| PI(4)P Grip (SidC-3C) (Echelon Bioscience, CAT#G-0402) |
| PI(4)P Mass ELISA Kit (Echelon Bioscience, CAT#K-4000E) |
| PI(4)P PIP Beads (Echelon Bioscience, CAT#P-B004A) |
| PI(4)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P004) |
| PI(5)P 4-Kinase (PIP4KII) Activity Assay (Echelon Bioscience, CAT#K-5400) |
| PI(5)P diC16 (Echelon Bioscience, CAT#P-5016) |
| PI(5)P diC4 (Echelon Bioscience, CAT#P-5004) |
| PI(5)P diC8 (Echelon Bioscience, CAT#P-5008) |
| PI(5)P diC8 (ammonium salt) (Echelon Bioscience, CAT#P-5008A) |
| PI(5)P PIP Beads (Echelon Bioscience, CAT#P-B005A) |
| PI(5)P PolyPIPosomes (Echelon Bioscience, CAT#Y-P005) |
| PI3-K alpha Inhibitor 2 (Echelon Bioscience, CAT#B-0304) |
| PI3-K Alpha Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300A) |
| PI3-K Beta Inhibitor Screening Service (Echelon Bioscience, CAT#T-1300B) |
| PI3-Kinase Activity AlphaScreen Assay (Echelon Bioscience, CAT#K-1300) |
| PI3-Kinase Activity ELISA: Pico (Echelon Bioscience, CAT#K-1000S) |
| PI3-Kinase Activity Fluorescence Polarization Assay (Echelon Bioscience, CAT#K-1100) |
| PI3-Kinase alpha (PI3Ka), active (Echelon Bioscience, CAT#E-2000) |
| PI3K (p110alpha/p85alpha), active (Echelon Bioscience, CAT#P27-18H) |
| PI3K (p110beta/p85alpha), active (Echelon Bioscience, CAT#P28-102H) |
| PI3Ka, E545K – Active Mutant (Echelon Bioscience, CAT#P27-15H) |
| PI4-Kinase Activity Assay (Echelon Bioscience, CAT#K-4000K) |
| PI4-Kinase beta (PI4Kb), active (Echelon Bioscience, CAT#P32-102G) |
| PI4-Kinase II alpha (PI4KIIa), active (Echelon Bioscience, CAT#P21-10G) |
| PI4-Kinase II beta (PI4KIIb), active (Echelon Bioscience, CAT#P22-10G) |
| PIK-93 (PI4KIIIb inhibitor) (Echelon Bioscience, CAT#B-0306) |
| PIP Array – Lipid-Protein Interaction Assay (Echelon Bioscience, CAT#P-6100) |
| PIP Beads Sample Pack (Echelon Bioscience, CAT#P-B00S) |
| PIP Pack (Echelon Bioscience, CAT#P-P100) |
| PIP Strips (Echelon Bioscience, CAT#P-6001) |
| PIP3 Mass ELISA Kit (Echelon Bioscience, CAT#K-2500S) |
| PKA Inhibitor (Echelon Bioscience, CAT#867-10) |
| PKA Substrate (Echelon Bioscience, CAT#866-25) |
| PKC Isoenzyme Inhibitor (myristoylated) (Echelon Bioscience, CAT#880-17) |
| PKC Isoenzyme Inhibitor / PKC Y translocation peptide (Echelon Bioscience, CAT#880-15) |
| PKC(e) Translocation Inhibitor – negative control (Echelon Bioscience, CAT#880-69) |
| PKG Substrate, Glasstide, H2Btide (Echelon Bioscience, CAT#870-74) |
| PKI (5-24), PKA Inhbibitor (Echelon Bioscience, CAT#890-98) |
| Plasmepsin II substrate (Echelon Bioscience, CAT#871-13) |
| PLPC (16:0/12:0 PC) (Echelon Bioscience, CAT#L-1612) |
| PLPC (16:0/18:2 PC) (Echelon Bioscience, CAT#L-1122) |
| PLPEth (16:0/18:2 PEth) (Echelon Bioscience, CAT#L-6020) |
| Pneumadin, rat (Echelon Bioscience, CAT#675-85) |
| PNPP Substrate & Solution (Echelon Bioscience, CAT#K-1208T) |
| Poly-Selective Phosphoinositide Phosphate Antibody (Echelon Bioscience, CAT#Z-P999) |
| POPC (16:0/18:1 PC) (Echelon Bioscience, CAT#L-1618) |
| POPEth (16:0/18:1 PEth) (Echelon Bioscience, CAT#L-6019) |
| Porphobilinogen (Echelon Bioscience, CAT#F-H020) |
| PPlases Substare, fluorogenic (Echelon Bioscience, CAT#869-20) |
| PPLases Substrate, colorimetric (Echelon Bioscience, CAT#869-10) |
| ProAM N20, human / Proadrenomedullin N-term 20 Peptide, huma (Echelon Bioscience, CAT#331-81) |
| ProAM N20, rat / Proadrenomedullin N terminal 20 peptide, rat (Echelon Bioscience, CAT#335-81) |
| Prodynorphin 228-256 (porcine) (Dynorphin B 29, Leumorphin) (Echelon Bioscience, CAT#274-56) |
| Propargyl-farnesol (Echelon Bioscience, CAT#S-0160) |
| Propargyl-geraniol (Echelon Bioscience, CAT#S-0110) |
| Prostate Specific Antigen Substrate (Echelon Bioscience, CAT#891-15) |
| Prot. Kin. C Pseudosubstrate Inhibitor (Echelon Bioscience, CAT#890-91) |
| Protein Kinase C (19-31), Protein Kinase C pseudosubstrate, (Echelon Bioscience, CAT#871-20) |
| Protein Kinase C Substrate (Echelon Bioscience, CAT#890-82) |
| Protein Kinase C substrate from EGF Receptor (Echelon Bioscience, CAT#871-55) |
| Protein Kinase Inhibitor Cdk2 (Echelon Bioscience, CAT#871-87) |
| Protein Tyrosine Phosphatase Substrate, fluorogenic (Echelon Bioscience, CAT#871-62) |
| Protoporphyrin IX (Echelon Bioscience, CAT#F-H050) |
| PS Lipid Microparticles (Echelon Bioscience, CAT#P-B1PS) |
| PS48 (PDK1 Activator) (Echelon Bioscience, CAT#B-0360) |
| PtdIns PIP Beads (Echelon Bioscience, CAT#P-B001) |
| PtdIns(4,5)P2 a-fluorovinylphosphate diC8 (Echelon Bioscience, CAT#P-FV4508) |
| PTEN Activity ELISA Kit (Echelon Bioscience, CAT#K-4700) |
| PTEN Enzyme, active (Echelon Bioscience, CAT#E-3000) |
| PTH Related Peptide (7-34) amide, human (Echelon Bioscience, CAT#231-94) |
| PTH Related Peptide [Asn10,Leu11] (7-34) amide, human (Echelon Bioscience, CAT#231-95) |
| PTH Related Peptide [Leu11, DTrp12] (7-34) amide, human (Echelon Bioscience, CAT#231-96) |
| PTH Related protein (1-40); Hypercalcemia Malignancy Factor (Echelon Bioscience, CAT#231-85) |
| Purified Anti-LPLA2 Antibody (Echelon Bioscience, CAT#Z-PLPLA2) |
| Purified Anti-Phosphatidylethanol Antibody (Echelon Bioscience, CAT#Z-PETH) |
| Purified Anti-PtdIns(3,4,5)P3 IgG (Echelon Bioscience, CAT#Z-P345B) |
| Purified Anti-PtdIns(3,4,5)P3 IgM (Echelon Bioscience, CAT#Z-P345) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034B) |
| Purified Anti-PtdIns(3,4)P2 IgG (Echelon Bioscience, CAT#Z-P034) |
| Purified Anti-PtdIns(3,5)P2 IgG (Echelon Bioscience, CAT#Z-P035) |
| Purified Anti-PtdIns(3)P IgG (Echelon Bioscience, CAT#Z-P003) |
| Purified Anti-PtdIns(4,5)P2 IgM (Echelon Bioscience, CAT#Z-P045) |
| Purified Anti-PtdIns(4)P IgM (Echelon Bioscience, CAT#Z-P004) |
| Purified Mouse Anti-LBPA (BMP) (Echelon Bioscience, CAT#Z-PLBPA) |
| Rabbit Anti-Human DGK Zeta Antibody (Echelon Bioscience, CAT#Z-DGKZ) |
| Ranakinin, frog (Echelon Bioscience, CAT#361-50) |
| Renin Substrate I (Echelon Bioscience, CAT#131-20) |
| Resveratrol (Echelon Bioscience, CAT#B-0021) |
| Rha(rac)C10C10 (Echelon Bioscience, CAT#RL10105) |
| Rha(rac)C12C12 (Echelon Bioscience, CAT#RL12125) |
| RR-SRC, Insulin receptor kinase substrate (Echelon Bioscience, CAT#870-68) |
| S-lysoPC, (18:0 LPC) (Echelon Bioscience, CAT#L-1518) |
| S1P Beads (Echelon Bioscience, CAT#S-6110) |
| S1P Fluorescein (Echelon Bioscience, CAT#S-200F) |
| S1P Lyase Fluorogenic Substrate (Echelon Bioscience, CAT#S-200U) |
| S1P TAMRA (Echelon Bioscience, CAT#S-200T) |
| S32826 [4-(Tetradecanoylamino)benzyl]phosphonic acid disodium salt] (Echelon Bioscience, CAT#L-3282) |
| S6 Phosphate Acceptor Peptide (Echelon Bioscience, CAT#890-72) |
| Sarafotoxin 6b (Echelon Bioscience, CAT#339-10) |
| Sarilesin – Angiotensin II [Sar1,Ile8] (Echelon Bioscience, CAT#131-63) |
| Sauvagine, frog (Echelon Bioscience, CAT#357-26) |
| SDT1 (Pyrimidine 5′-nucleotidase) (Echelon Bioscience, CAT#E-20SDT1) |
| Select-HA 1000k (Echelon Bioscience, CAT#HYA-1000KEF-1) |
| Select-HA 500k (Echelon Bioscience, CAT#HYA-500KEF-1) |
| Select-HA 50k (Echelon Bioscience, CAT#HYA-50KEF-1) |
| Select-HA 601k (Echelon Bioscience, CAT#HYA-601KEF-1) |
| Select-HA HiLadder (Echelon Bioscience, CAT#HYA-HILAD-20) |
| Select-HA LoLadder (Echelon Bioscience, CAT#HYA-LOLAD-20) |
| Senktide ;Substance P [Suc-,Asp6,Me-Phe8] (6-11) (Echelon Bioscience, CAT#712-14) |
| SF1670 (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0350) |
| Sheep Anti-Human DGK Alpha Peptide Antibody (Echelon Bioscience, CAT#Z-DGKA) |
| SHIP2 Lipid Phosphatase Enzyme, active (Echelon Bioscience, CAT#E-1000) |
| SHIP2 Reaction Buffer (Echelon Bioscience, CAT#K-S2RB) |
| Shuttle PIP Kit, PtdIns(3,4,5)P3 (Echelon Bioscience, CAT#P-9039) |
| Shuttle PIP Kit, PtdIns(3,4)P2 (Echelon Bioscience, CAT#P-9034) |
| Shuttle PIP Kit, PtdIns(3,5)P2 (Echelon Bioscience, CAT#P-9035) |
| Shuttle PIP Kit, PtdIns(3)P (Echelon Bioscience, CAT#P-9003) |
| Shuttle PIP Kit, PtdIns(4,5)P2 (Echelon Bioscience, CAT#P-9045) |
| Shuttle PIP Kit, PtdIns(4)P (Echelon Bioscience, CAT#P-9004) |
| Shuttle PIP Kit, PtdIns(5)P (Echelon Bioscience, CAT#P-9005) |
| SKI-178 (SPHK1 Inhibitor) (Echelon Bioscience, CAT#B-0028) |
| SLPEth (18:0/18:2 PEth) (Echelon Bioscience, CAT#L-6022) |
| SMPC (18:0/14:0 PC) (Echelon Bioscience, CAT#L-1814) |
| sn-1-Fluorescein-labeled Cardiolipin (Echelon Bioscience, CAT#L-C16F) |
| Sn(IV) Protoporphyrin IX, 14325-05-4 (Echelon Bioscience, CAT#F-H080) |
| SNP-1 (Echelon Bioscience, CAT#888-10) |
| Somatostatin 28 (1-12) (Echelon Bioscience, CAT#691-77) |
| Somatostatin 28, cyclic (Echelon Bioscience, CAT#691-65) |
| Somatostatin Antagonist, cyclic / Coy (Echelon Bioscience, CAT#691-63) |
| Somatostatin, cyclic (Echelon Bioscience, CAT#691-25) |
| SOPEth (18:0/18:1 PEth) (Echelon Bioscience, CAT#L-6021) |
| Sorbitan monostearate (Echelon Bioscience, CAT#R-1318) |
| Spantide ([D-Arg1,D-Trp7,9,Substance P Leu11] (Echelon Bioscience, CAT#712-31) |
| Spantide II (Echelon Bioscience, CAT#712-36) |
| Specific NFAT Inhibitor / VIVIT-16 (Echelon Bioscience, CAT#887-16) |
| Sperm Activating Peptide, Sea Urchin (Echelon Bioscience, CAT#610-52) |
| Sphinganine-biotin (Echelon Bioscience, CAT#S-110B) |
| Sphinganine-fluorescein (Echelon Bioscience, CAT#S-110F) |
| Sphingo Arrays (Echelon Bioscience, CAT#S-6001) |
| Sphingo Beads (Echelon Bioscience, CAT#S-6100) |
| Sphingo Beads Sample Pack (Echelon Bioscience, CAT#P-B00SS) |
| Sphingo Strips (Echelon Bioscience, CAT#S-6000) |
| Sphingomyelin Beads (Echelon Bioscience, CAT#P-B0SM) |
| Sphingosine 1-Phosphate (S1P) (Echelon Bioscience, CAT#S-2000) |
| Sphingosine 1-Phosphate Antibody (Echelon Bioscience, CAT#Z-P300) |
| Sphingosine 1-Phosphate Assay Service (Echelon Bioscience, CAT#T-1900) |
| Sphingosine 1-phosphate biotin (S1P-biotin) (Echelon Bioscience, CAT#S-200B) |
| Sphingosine 1-Phosphate ELISA Kit (Echelon Bioscience, CAT#K-1900) |
| Sphingosine 1-Phosphate Lyase Overexpression Lysate, active (Echelon Bioscience, CAT#E-5000L) |
| Sphingosine 1-Phosphate Lyase, active (Echelon Bioscience, CAT#E-5000P) |
| Sphingosine kinase 1, active (Echelon Bioscience, CAT#E-K068) |
| Sphingosine kinase 2, active (Echelon Bioscience, CAT#E-K069) |
| Sphingosine Kinase Activity Assay (Echelon Bioscience, CAT#K-3500) |
| Sphingosine Kinase Inhibitor (SKI-II) (Echelon Bioscience, CAT#B-0024) |
| Sphingosine-biotin (Echelon Bioscience, CAT#S-100B) |
| Sphingosine-fluorescein (Echelon Bioscience, CAT#S-100F) |
| Sphingosine-tetramethylrhodamine (Echelon Bioscience, CAT#S-100T) |
| Squalene, purified (Echelon Bioscience, CAT#S-0300) |
| SS14 Tumor Inhibitor Analog (Echelon Bioscience, CAT#691-60) |
| Stercobilin Hydrochloride (Echelon Bioscience, CAT#F-H150) |
| Substance P (Echelon Bioscience, CAT#711-25) |
| Substance P (5-11) / Hepta-Substance P (Echelon Bioscience, CAT#711-66) |
| Substance P [Nle11] (Echelon Bioscience, CAT#711-36) |
| Substance P [Sar9] (Echelon Bioscience, CAT#711-48) |
| Substance P [Tyr8] (Echelon Bioscience, CAT#711-33) |
| Substance P, (p-Cl-Phe7,8) (Echelon Bioscience, CAT#712-55) |
| Substrate for E. Coli Leader Peptidase (Echelon Bioscience, CAT#887-10) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-77) |
| Substrate for Factor VIIa (Echelon Bioscience, CAT#871-78) |
| Suc-Ala-Ala-Ala-Ala-pNA (Echelon Bioscience, CAT#876-02) |
| Suc-Ala-Ala-Leu-pNA (Echelon Bioscience, CAT#876-03) |
| Suc-Ala-Ala-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-32) |
| Suc-Ala-Ala-Pro-Phe-AFC (Pancreatic Elastase Substrate (human), fluorogenic) (Echelon Bioscience, CAT#881-34) |
| Suc-Ala-Ala-Pro-Phe-AMC (Chymotrypsin Substrate, fluorogenic) (Echelon Bioscience, CAT#881-31) |
| Suc-Ala-Ala-Pro-Phe-pNA (Pancreatic Leukocyte Elastase (human) Substrate, colorimetric) (Echelon Bioscience, CAT#881-30) |
| Suc-Gly-Gly-Phe-pNA (Chymotrypsin Substrate , colorimetric) (Echelon Bioscience, CAT#881-33) |
| Suc-Leu-Leu-Val-Tyr-AFC (Chymotrypsin like Enzyme Substrate, fluorogenic) (Echelon Bioscience, CAT#881-21) |
| Suc-Leu-Leu-Val-Tyr-AMC (Proteosome Substrate) (Echelon Bioscience, CAT#881-18) |
| Suc-Leu-Tyr-4-methoxy-2-naphthylamide (Calpain I & II, Papain Substrate, fluorogenic) (Echelon Bioscience, CAT#878-01) |
| Suc-Phe-Ala-His-Phe-AMC (Echelon Bioscience, CAT#877-10) |
| Suc-Phe-Ala-His-Phe-pNA (Echelon Bioscience, CAT#876-04) |
| Synthetic 16:0 Cardiolipin (Echelon Bioscience, CAT#L-C160) |
| Synthetic 16:0 Monolysocardiolipin (Echelon Bioscience, CAT#L-M160) |
| Syntide 2, CaMKII Substrate (Echelon Bioscience, CAT#105-77) |
| TACE Substrate (Fluorogenic) (Echelon Bioscience, CAT#860-78) |
| Thio-ccPA (Echelon Bioscience, CAT#L-7118) |
| Thrombin , Trypsin , Papain Substrate (Echelon Bioscience, CAT#920-13) |
| Thrombin Receptor Activator Peptide 6 / TRAP-6 (Echelon Bioscience, CAT#920-51) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-29) |
| Thrombin Receptor Agonist (Echelon Bioscience, CAT#920-53) |
| Thrombin Receptor Agonist; (Echelon Bioscience, CAT#920-52) |
| Thrombin Receptor Antagonist (Echelon Bioscience, CAT#920-50) |
| Thymosin b4 (1-4) (Echelon Bioscience, CAT#885-21) |
| TMB Precipitating (Echelon Bioscience, CAT#K-TMBP) |
| TMR Labeled Carrier 1 (Neomycin B Sulfate) (Echelon Bioscience, CAT#P-9C1R) |
| TMR Labeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2R) |
| TNF coverting enzyme substrate (Echelon Bioscience, CAT#882-50) |
| Trismethoxyresveratrol (Echelon Bioscience, CAT#B-0022) |
| Tyr(PO3H2)4 Angiotensin II, human (Echelon Bioscience, CAT#131-48) |
| Tyrosine Specific Protein Kinase Inhibitor Peptide A (Echelon Bioscience, CAT#890-88) |
| Unlabeled Shuttle PIP Carrier 1 (Echelon Bioscience, CAT#P-9C1) |
| Unlabeled Shuttle PIP Carrier 2 (Echelon Bioscience, CAT#P-9C2) |
| Unlabeled Shuttle PIP Carrier 3 (Echelon Bioscience, CAT#P-9C3) |
| Uridine Diphosphate-Bodipy-FL (UDP-Bodipy-FL) (Echelon Bioscience, CAT#N-100F) |
| Urobilin Hydrochloride (Echelon Bioscience, CAT#F-H140) |
| Urocortin, human (Echelon Bioscience, CAT#353-10) |
| Urocortin, rat (Echelon Bioscience, CAT#353-20) |
| Urodilatin (Echelon Bioscience, CAT#151-30) |
| Uroporphyrin I dihydrochloride (Echelon Bioscience, CAT#F-H040) |
| Uroporphyrin III dihydrochloride (Echelon Bioscience, CAT#F-H030) |
| Urotensin I, carp (Echelon Bioscience, CAT#817-40) |
| Urotensin I, suckerfish (Echelon Bioscience, CAT#817-30) |
| Urotensin II, human (Echelon Bioscience, CAT#817-50) |
| Vasoactiv Intestinal Peptide [Lys1,Pro2,5,Arg3,4,Tyr6] / VI (Echelon Bioscience, CAT#491-32) |
| Vasoactive Intestinal Constrictor / Mouse Beta Endothelin / (Echelon Bioscience, CAT#337-10) |
| Vasoactive Intestinal Peptide (6-28),human, porcine, rat / V (Echelon Bioscience, CAT#491-29) |
| Vasoactive Intestinal Peptide / VIP, human, porcine, rat (Echelon Bioscience, CAT#491-25) |
| Vasopressin ( Pmp1,Tyr(Et)2,Val4,Arg8 ) cyclic (Echelon Bioscience, CAT#670-32) |
| Vasopressin [Arg8] (AVP), cyclic (Echelon Bioscience, CAT#670-18) |
| Vasopressin [Deamino-Pen1,Val4,D-Arg8] (Echelon Bioscience, CAT#670-36) |
| Vasopressin [Lys-8] (Echelon Bioscience, CAT#670-17) |
| Vasopressin [Pmp1, Tyr(0Me)2, Arg8] (Echelon Bioscience, CAT#670-24) |
| Vasotocin [Arg8] cyclic (Echelon Bioscience, CAT#670-65) |
| Versican G1 Domain (Echelon Bioscience, CAT#G-HA01) |
| VIP Antagonist [Ac-Tyr1,D-Phe2]-GRF(1-29)NH2 (Echelon Bioscience, CAT#491-41) |
| VO-OHpic (PTEN Inhibitor) (Echelon Bioscience, CAT#B-0351) |
| VPC 23019 (S1P1/3 Antagonist) (Echelon Bioscience, CAT#B-0061) |
| Whole-Cell MEP Pathway-Selective Antibacterial Screening Assay Service (Echelon Bioscience, CAT#T-2000) |
| Wortmannin (Echelon Bioscience, CAT#B-0222) |
| XY-14 (Lipid Phosphate Phosphatase 1 Inhibitor) (Echelon Bioscience, CAT#L-9218) |
| XY-17 (LPA3 Agonist) (Echelon Bioscience, CAT#L-9118) |
| XY-4 (LPA analog) (Echelon Bioscience, CAT#L-1160) |
| Z-Ala-Ala-Asp-AFC (Cathepsin S Substrate, fluorogenic) (Echelon Bioscience, CAT#874-06) |
| Z-Ala-Arg-Arg-MbNA (Cathepsin B Substrate II, fluorogenic) (Echelon Bioscience, CAT#866-29) |
| Z-Ala-Lys-Arg-AMC (Echelon Bioscience, CAT#877-03) |
| Z-Arg-Arg-AMC (Cathepsin B substrate, fluorogenic) (Echelon Bioscience, CAT#866-30) |
| Z-Arg-Arg-MbNA (Cathepsin B Substrate, fluorogenic) (Echelon Bioscience, CAT#866-31) |
| Z-Arg-Arg-pNA (Cathepsin B substrate, colorimetric) (Echelon Bioscience, CAT#866-27) |
| Z-Asp-Glu-Val-Asp-AFC (Caspase 3 (Apopain) Substrate) (Echelon Bioscience, CAT#863-18) |
| Z-Asp-Glu-Val-Asp-pNA (Caspase 3 (Apopain) substrate) (Echelon Bioscience, CAT#861-20) |
| Z-Glu-Ala-Asp-CHO (Echelon Bioscience, CAT#878-05) |
| Z-Gly-Gly-Arg-AMC (Urokinase Substrate III, fluorogenic) (Echelon Bioscience, CAT#869-25) |
| Z-Gly-Gly-Leu-AMC (Proteasome Substrate, fluorogenic) (Echelon Bioscience, CAT#882-31) |
| Z-Gly-Val-Val-AMC (Echelon Bioscience, CAT#877-04) |
| Z-Ile-Glu-Thr-Asp-AFC (Granzyme B Substrate) (Echelon Bioscience, CAT#863-56) |
| Z-Ile-Glu-Thr-Asp-pNA (Granzyme B Substrate) (Echelon Bioscience, CAT#863-61) |
| Z-Leu-Arg-AMC (Cathepsin, Kallikrein, Falcipain II substrate, fluorogenic) (Echelon Bioscience, CAT#877-14) |
| Z-Leu-Leu-Glu-AMC (Proteasome Substrate 2, fluorogenic) (Echelon Bioscience, CAT#882-21) |
| Z-Leu-Leu-Leu-AMC (Proteasome Substrate 1, fluorogenic) (Echelon Bioscience, CAT#882-20) |
| Z-Leu-Leu-Phe-CHO (Proteasome Inhibitor 2) (Echelon Bioscience, CAT#882-12) |
| Z-Phe-Ala-pNA (Echelon Bioscience, CAT#876-05) |
| Z-Phe-Arg-AFC (Cathepsin L Substrate, fluorogenic) (Echelon Bioscience, CAT#866-75) |
| Z-Phe-Arg-AMC (Kallikrein substrate) (Echelon Bioscience, CAT#871-75) |
| Z-Phe-CHO (Echelon Bioscience, CAT#878-06) |
| Z-Phe-Tyr-CHO (Cathepsin L Inhibitor) (Echelon Bioscience, CAT#866-28) |
| Z-Tyr-Val-Ala-Asp-AFC (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-17) |
| Z-Tyr-Val-Ala-Asp-pNA (Caspase 1 Substrate) (Echelon Bioscience, CAT#861-28) |
| Z-Val-Asp-Val-Ala-Asp-AFC (Caspase 2 (ICH-1) Substrate) (Echelon Bioscience, CAT#863-49) |
| Z-Val-Gly-Arg-pNA (Urokinase Substrate I, colorimetric) (Echelon Bioscience, CAT#869-31) |
| Z-Val-Ile-Ala-AMC (IRCM Serine Protease I Substrate, fluorogenic) (Echelon Bioscience, CAT#877-05) |
| Z-Val-Lys-Met-AMC (Proteasome Substrate 4, fluorogenic) (Echelon Bioscience, CAT#882-23) |
| Z-Val-Phe-CHO (Calpain Inhibitor III) (Echelon Bioscience, CAT#870-50) |
| Z-Val-Pro-Arg-pNA (Echelon Bioscience, CAT#876-08) |
| Z-Val-Val-Arg-AFC (Echelon Bioscience, CAT#874-01) |
| Zn (II) Deuteroporphyrin IX 2,4 bisethylene glycol (Echelon Bioscience, CAT#F-H090) |
| Zn Protoporphyrin IX (Echelon Bioscience, CAT#F-H060) |
| ZSTK474 (PI3K Inhibitor) (Echelon Bioscience, CAT#B-0307) |
更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com
" data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="Echelon Biosciences"> Echelon Biosciences
Prozyme公司位于美国加州,为广大客户提供诊断和科研所需的标记物、蛋白质与酶。Prozyme 于2003年1月收购了Glyko®产品线,包括研究糖类的酶及相关试剂。其中也包括Glyko®于1999年收购的Oxford GlycoSciences,Ltd 公司生化试剂产品线。
ProZyme is now a part of Agilent Technologies, Inc.
ProZyme, Inc. was founded in 1990 with a vision of establishing a high-quality, value-added and customer-driven biochemical reagent company. We are proud to continue to provide the highest level of products, services and support to our customers at large and small biotechnology, biopharmaceutical and academic institutions across the world.
ProZyme公司产品系列:
(1)糖生物学研究工具(Glyko.系列)
(2)PhycoLink. 荧光结合试剂( 抗体/ 蛋白标记) PE, PerCP conjugates, BPE conjugates, CPC conjugates,生物素,纯化试剂盒,结合试剂盒,标记二抗
(3)PhycoLink.纯化与标记试剂盒/ Purification and Conjugation Kits
(4) PhycoProTM 藻胆蛋白/ Phycobiliproteins
(5)生物素结合蛋白/ Biotin-binding Proteins 链亲和素
(6)固定化链亲和素/ Immobilized Streptavidin 琼脂糖-链亲和素
(7))链亲和素结合物/ Streptavidin Conjugates 链亲和素- AP,链亲和素- HRP
(8) Marker Enzyme 半乳糖苷酶
(9)位点特异性蛋白酶/ Site-specific Protease Factor Xa (lyophilized)
(10)客户定制结合服务或其他
<更多详情请联系
艾美捷科技有限公司
全国服务热线:400-6800-868
邮箱:sales@amyjet.com
网站:www.amyjet.com

艾美捷科技代理EliteCell品牌。
EliteCell公司在细胞培养添加物市场拥有超过10年的丰富cGMP制造经验,专注于开发细胞疗法研究和商业开发的先进解决方案。EliteCell与美国获得FDA许可,并于AABB认证的血液中心合作,提供100%可追溯的产品。EliteCell公司致力于为细胞治疗行业和研究提供安全有效的细胞培养产品。
< " data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="艾美捷科技代理EliteCell品牌"> 艾美捷科技代理EliteCell品牌
RNAssist专注于单细胞分析中生物大分子的稳定剂研发,其专利性的产品在保障RNA和生物分子稳定性的同时,还可以有效保存细胞形态,和使病毒/细菌失活。三个系列的产品,包括vivoPHIX™, genoPHIX™和virusPHIX™,他们都能够对临床样本提供有效保护和灭活病原体,同时各自又有不同的功效,适用于细胞&组织固定、ISH、IF、scRNA-seq、二代测序等领域。
<【vivoPHIX】
vivoPHIX™ 单细胞组学专用组织RNA稳定剂,10ml
vivoPHIX™ (10ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-10
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,20ml
vivoPHIX™ (20ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-20
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,30ml
vivoPHIX™ (30ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-30
<vivoPHIX™ 单细胞组学专用组织RNA稳定剂,50ml
vivoPHIX™ (50ml) – RNA stabilisation solution for single cell analysis
货号:RD-VIVO-50
vivoPHIX™单细胞组学专用组织RNA稳定剂,可以用于组织中RNA的固定保存,特别适合后续多组学检测,包括scRNA-seq试验和SMART-seq试验。其发挥的作用包括:生物分子的稳定(RNA、DNA和磷酸化蛋白)、细胞固定、组织分离和病毒/细菌灭活。
<【genoPHIX】
genoPHIX™ 全组分组织稳定剂,20ml
genoPHIX™ 20ml: For projects involving large tissue samples
货号:RD-GENO-20
<genoPHIX™ 全组分组织稳定剂,50ml
genoPHIX™ 50ml: For projects involving large tissue samples
货号:RD-GENO-50
genoPHIX™ 全组分组织稳定剂,适合应用于石蜡包埋组织样品。其独特的性质,使得这个试剂可以从石蜡包埋组织中提取核酸并保持其稳定性,是IHC、IF、FISH、荧光蛋白检测的理想选择。
【virusPHIX】
<virusPHIX™ – RNA Stabiliser and virus inactivation reagent
virusPHIX™ RNA稳定及病毒灭活试剂
货号:N/A
(1)稳定组织样品中的RNA、DNA和磷酸化蛋白;
(2)对组织样品中病毒、细菌、酵母进行有效灭活,提高生物安全性;
(3)适合分子测试;
(4)可与多种RNA提取试剂盒配合使用,包括:RNeasy™, QIAamp™, QIAsymphony™, QIAcube™, Nuclisens™, GeneXpert™and Filmarray™
(5)无毒、稳定、常温运输。
< " data-original="http://mabtech.51antibodies.com/template/company/xys_lvse/skin/image/lazyLoad.jpg" alt="RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)"> RNAssist系列稳定剂(virusPHIX™、genoPHIX™、vivoPHIX™)地址:武汉市洪山区光谷大道35号光谷总部国际时代 二期1栋1301
电话:18327026838
传真:18327026838
邮箱:sales@amyjet.com
0.3252